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1. SUMMARY 
 
 
Mot1 is an essential factor that in response to physiological signals regulates global 
redistribution of TATA box-binding protein (TBP), thereby ensuring rapid and tight control of 
the transcription process in eukaryotes. Mot1 belongs to Swi2/Snf2 family (Switching 
defective/Sucrose nonfermenting 2) of helicase-like translocases, which form a large and 
diverse class of proteins playing important roles in DNA replication, recombination, repair, 
and transcription. Despite all the efforts, it is not clear how Swi2/Snf2 ATPase motors couple 
nucleotide binding and hydrolysis to alteration of protein–DNA contacts in their substrates.  
Crystal structure of the N-terminal HEAT repeat domain of the Encephalitozoon 
cuniculi Mot1 (Mot1NTD) in complex with TBP showed how Mot1 binds to its substrate after 
the remodeling reaction has taken place (“product” complex). This work presents the 3.8 Å 
X-ray structure of the E. cuniculi Mot1NTD in complex with TBP, DNA, and NC2, another 
transcriptional regulator, thereby providing the first atomic view at a Swi2/Snf2 remodeler 
bound to its protein and DNA substrate in a single complex. The analysis of the structural 
data suggests that ATP-dependent dissociation of protein substrates from DNA is preceded by 
Mot1-induced ATP-independent destabilization of the TBP–DNA and NC2–DNA 
interactions. Second crystal structure described in this thesis, the E. cuniculi Mot1NTD–TBP–
NC2β complex at 3.3 Å resolution, represents so far uncharacterized dimeric assembly in 
which the histone fold domain of the NC2β subunit adapts unexpectedly extended 
conformation. Protein–protein crosslinking coupled to mass spectrometry experiments (CX-
MS) performed on the Mot1–TBP–DNA–NC2 complex in the presence of different 
nucleotides enabled to statistically determine the relationship between the conformation and 
the nucleotide state of the ATPase domain of Mot1 (Mot1CTD). Combination of CX-MS and 
modeling methods, which was further independently confirmed by the negative stain electron 
microscopy (EM) studies, provided the means to define the localization of Mot1CTD within 
the full complex. Finally, the structural analysis and biochemical methods enabled to propose 
the pseudoatomic model of the Mot1–TBP–DNA–NC2 complex.  
These results reveal structural and functional similarities between Mot1 and other 
Swi2/Snf2 enzymes, which are in particular relevant to nucleosome-related activities applied 
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by chromatin remodeling machineries. Additionally, the initial structural data provide novel 
insights into possible distinct roles for Mot1 and NC2 in transcriptional regulation. 
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2. INTRODUCTION 
 
 
Regulation of transcription in eukaryotes is a highly dynamic process requiring the 
coordinated interaction of multiple regulatory proteins. Initiation of transcription by all RNA 
polymerases (RNA pol) requires TATA box-binding protein (TBP), which is a limiting factor 
for this process [1], [2]. Due to extremely long half-life time of the TBP–DNA complex—up 
to 50 minutes in vitro [3]—living organisms require rapid and tight regulation of TBP’s 
redistribution in global response to physiological signals. 
On class II promoters, driving the expression of protein-encoding genes, global 
response to physiological signals can be directly modulated by two conserved and essential 
TBP regulators, Mot1 (Modifier of transcription 1, also denoted as BTAF1 in human) and 
NC2 (Negative Cofactor 2), a heterodimer composed of α and β subunits.  
 
 
2.1 Mot1 
 
2.1.1 Discovery 
 
In addition to the multisubunit RNA pol II enzyme itself, in vitro transcription by RNA 
polymerase II requires a set of at least five general transcription factors (GTFs): TBP, TFIIB, 
TFIIE, TFIIF, and TFIIH [4]. GTFs were first purified from human whole cell extracts 
(WCE) and classified according to their affinity to phosphocellulose column [5]. In human 
WCE, two of the distinct GTF fractions, called B-TFIID and D-TFIID, were shown to 
contain TBP and support basal transcription in vitro [6]. Subsequently, the B-TFIID fraction 
was shown to exhibit ATPase activity and, apart from TBP, to contain a 170 kDa polypeptide 
that was not present in the D-TFIID fraction [7]. Electrophoretic mobility shift assays 
(EMSAs) and DNase I footprinting experiments performed by the Hahn group on GTFs 
purified from Saccharomyces cerevisiae WCE demonstrated the presence of a factor 
responsible for the ATP-dependent inhibition of TBP–DNA interaction [8]. Finally, this 
ATP-dependent inhibitor (ADI) was shown to be encoded by MOT1 gene and to function as 
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an RNA pol II-specific repressor essential for the yeast cell grow [9]–[12]. Subsequently, 
other groups published analogous results, identifying yeast TBP-associated factor Taf170 as 
Mot1 and TAFII170/TAF-172 as its human ortholog [13]–[15]. Mot1 in Drosophila, Helicase 
89B (Hel89B), was also partially characterized [16].  
As much as 75% of the total TBP pool in human cells was shown to be tightly 
associated with BTAF1 in the B-TFIID form [6]. Consistently, Wade et al. reported that even 
more than 90% of TBP pool in yeast is Mot1-bound [17]. However, some studies in HeLa 
cells showed that Mot1–TBP association is not so abundant [14]. Correspondingly, Poon et 
al. showed that only up to 5% of the total TBP pool co-immunoprecipitates with Mot1 in 
yeast [13]. Most likely, these discrepancies are due to the differences in the purification 
protocols. In any case, no free TBP was found in HeLa WCE [6]. 
 
 
2.1.2 Mot1 function in vivo 
 
Global analysis of the changes in mRNA expression levels in mot1-1 mutant revealed that the 
conditional depletion of Mot1 upon the shift to nonpermissive temperature affects 
transcription of 11–15% of yeast genes [18], [19]. In the case of the temperature sensitive 
mot1-14 mutant at permissive temperature, 3% of all of the yeast genes tested were affected 
[20]. Similarly, approximately 4% of all genes were deregulated in a mouse cell line 
defective in the integrity of the BTAF1–TBP complex [21]. 
Although Mot1 has been first shown to have a negative impact on transcription [8], 
[9], [11], [22], large body of data demonstrates an activating role for Mot1 on certain 
promoters not only in vitro [23], [24], but also in vivo in yeast [18], [19], [25]–[27] as well as 
in vivo in mouse [21]. Since both activation and repression functions of Mot1 require its 
functional ATPase activity [20], Mot1’s localization to both activated and repressed 
promoters in vivo could suggest that these effects depend on the promoter context in which 
Mot1 is found [19]. How could the activity to dissociate TBP from promoter lead to 
activation of some sets of genes? 
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Mot1 dissociates nonproductive TBP–DNA complexes 
Mot1 associates with multiple positions within the protein coding regions of the yeast 
genome [19], [28]. This is, however, unusual for a transcriptional regulator. Moreover, 
Mot1’s conditional loss increases TBP occupancy not only on promoter, but also on coding 
sequences [19]. The presence of Mot1–TBP complexes at coding regions can be explained by 
the fact that TBP is known to bind to high-affinity nonpromoter sites [3]. Recently published 
experiments performed in ∆SET2 and ∆ASF1 strains (impaired for the maintenance of 
repressive chromatin) showed synthetic growth phenotypes caused by anchor-away depletion 
of Mot1, thereby confirming a role for Mot1 in suppression of intragenic transcription [30]. 
Mot1 conditional depletion was also found to result in high levels of aberrant antisense 
transcripts resulting from TBP being incorporated in functional PICs at cryptic sites [31], 
[32]. Moreover, TBP and Mot1–TBP complexes were shown to bind to the TATA promoter 
elements defined by the opposite strand, which do not support functional transcription [29]. 
Thus, it appears that the ability to release TBP trapped in nonproductive transcriptional 
complexes at the promoter and/or nonpromoter sites could at least partially account for 
Mot1’s activation function. 
 
Mot1 nucleates alternative PIC assemblies 
Numerous chromatin immunoprecipitation (ChIP) studies and mRNA expression profiling 
arrays have shown that Mot1’s and TBP’s occupancy is particularly high not only on 
promoters that are characterized by lowered but also enhanced mRNA expression levels [18], 
[19]. Therefore, it has been proposed that on some promoters Mot1 could directly contribute 
to the transcription initiation process in a positive manner. This question was further 
addressed in the analysis of GTFs association to Mot1’s target promoters under normal and 
stress conditions [33]. Sequential ChIP data showed that under normal conditions Mot1 does 
not occupy promoters with TFIIA, TFIIB or RNA pol II. However, significant co-occupancy 
of Mot1, TFIIB and elongation-competent RNA pol II was observed upon heat shock or 
under hyperosmotic conditions. Therefore, is has been proposed that under environmental 
stress conditions Mot1 could be involved in the formation of distinct forms of PICs [33].  
Further support for this hypothesis was shown by the Auble’s group, where Mot1-
activated BNA1 and URA1 promoters in WT and mot1-42 cells were investigated [34]. 
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Conditional depletion of Mot1 caused increased TBP levels at these promoters, whereas 
TFIIB and RNA pol II occupancy as well as mRNA levels were greatly decreased. These 
findings indicated that, in order to activate these promoters, Mot1 is not necessarily required 
to load TBP, but rather directs the formation of functional PICs [34]. More detailed 
functional and structural characterization of the URA1 promoter also performed by the 
Auble’s group showed that Mot1’s positive function at URA1 is partially facilitated by the 
displacement of improperly oriented TBP [29]. However, the activation of the analyzed 
promoter was still Mot1-dependent, even if a consensus TATA box sequence in proper 
orientation was introduced instead of the endogenous one [29]. Thus, although fixing TBP’s 
reverse orientation was critical for the activation of URA1, Mot1-catalyzed redistribution of 
TBP’s orientation does not entirely account for the activator role, further supporting the 
hypothesis for a direct role of Mot1 in PIC assembly.  
Taken together, according to some results, Mot1–TBP complex on some promoters 
appears as a form of transcriptionally active TBP that forms preinitiation complexes 
analogous to TFIID. At activated promoters Mot1 could use the energy from ATP hydrolysis 
to reorganize PICs by inducing a conformational change in the TBP-containing complexes 
[20]. Alternatively, Mot1 at activated promoters could use a novel enzymatic activity, which 
has not been yet characterized.  
 
Mot1 redistributes TBP between the TATA and TATA-less promoter sites 
The first hypothesis that Mot1-dependent effects on transcription are affected by the presence 
or quality of the promoter sequence was after Mot1 was shown to be required for efficient in 
vitro transcription from yeast HIS3 TATA-less but not HIS3 TATA-containing promoter [19], 
[24], [35]. A similar trend was observed in Drosophila, where by RNAi depletion it was 
shown that TATA-containing promoters are preferentially repressed and, conversely, 
DPE-dependent promoters are preferentially activated by Mot1 [36]. This led to the 
hypothesis that Mot1 represses transcription from TATA promoters and activates TATA-less 
transcription by redistribution of TBP.  
Importantly, functional TATA elements are enriched among heat shock promoters; on 
the contrary, the TFIID-dominated promoters, which drive the expression of housekeeping 
genes, do not generally possess canonical TATA boxes [26], [37]. Indeed, most of the Mot1-
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repressed genes (77%) are induced during the diauxic shift, as part of environmental stress 
response or during mating and sporulation [20]. For example, a very elegant study involving 
ChIP and time-dependent monitoring of mRNA levels of TATA box-regulated HSP26 gene 
(coding for small heat shock protein) performed in WT and mot1 mutant strains showed that 
Mot1—although originally identified as the repressor of this gene [20]—in fact antagonizes 
the heat shock-activated state of HSP26 [34]. Analogous conclusions have been drawn after 
the analysis of the same promoter during its heat shock activation in Mot1-depleted cells 
using anchor-away approach [26]. Recent TBP ORGANIC profiling experiments (sequencing 
of occupied regions of genomes from affinity-purified naturally isolated chromatin) 
performed in mot1-42 strain at restrictive temperature additionally demonstrated that over 
80% of the sites characterized by increased TBP occupancy possess robust TATA boxes [28].  
The differential sensitivity of Mot1-affected promoters seems to be related to their 
regulation by different co-activator complexes. For example, genome-wide studies reported 
high co-occupancy of Mot1 and SAGA (Spt–Ada–Gcn5 acetyltransferase) complex at the 
target genes during acute heat shock [38]. Moreover, the TBP-interacting Spt3–Spt8 SAGA 
module was shown to be essential for the Mot1 recruitment to some promoters [39]. 
Additionally, yeast ∆SPT3 mutation causes synthetic lethality in mot1-24 [25] and synthetic 
sickness in mot1-1 background [39]. Analogously, anchoring Mot1 in ∆SPT7 or ∆SPT3/SPT8 
mutant yeast cells causes synthetic lethality, further suggesting a functional interaction 
between Mot1 and SAGA complex [26]. What factors are responsible for the Mot1's 
recruitment to TATA-less promoters still awaits further investigation. 
 
Mot1 and regulation of RNA pol I- and pol III-driven transcription 
Although RNA pol III promoters often have consensus TATA elements that affect 
transcription via the specific DNA-binding activity of TBP [40], [41], initial studies of 
selected RNA pol I and RNA pol III-transcibed promoters showed that they are not regulated 
by Mot1 [9], [24]. However, more recent studies including higher number of promoters point 
out at a possible direct role for Mot1 in rRNA transcription and processing [42]. Furthermore, 
pull-down experiments performed with the N-terminus of Drosophila Hel89B showed that 
this factor can not only bind to dTBP but also to TBP-related factor-1 (dTRF-1) [43]. 
Analogously, next to yeast and human TBP, the N-terminus of human BTAF1, although with 
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slightly reduced efficiency than hTBP, binds to dTRF-1 [44]. Therefore, although Mot1’s 
regulatory role has been mostly linked to its activity at promoters of protein-encoding genes, 
a possible functional link between Mot1 and transcription by other RNA polymerases is not 
entirely excluded and needs to be analyzed on a genome-wide scale in more detail. 
 
 
2.1.3 Structural organization of the Mot1–TBP complex 
 
Mot1–TBP interaction controls Mot1’s nuclear localization [43], is required for the 
stimulation of the Mot1’s central ATPase activity [14], [45]–[47], and delineates Mot1’s 
essential function in vivo [22], [37], [43]. In yeast, overexpression of TBP can suppress the 
negative-dominant phenotype of the C-terminally truncated Mot1 mutants, which form 
dead-end Mot1–TBP–DNA complexes in vitro [45]. Correspondingly, the N-terminal part of 
human BTAF1 was shown to be important for TBP's recognition in yeast two-hybrid assay 
[44]. Interestingly, TBP mutations localized not only on the convex, but also on its concave, 
DNA-binding surface abolish Mot1–TBP interaction [48], [49]. 
The first structural information that supported mentioned above in vitro and in vivo 
results was obtained from the electron microscopy studies (EM) of the native as well as 
recombinant human BTAF1–TBP complexes published by Timmers and co-workers [50]. 
The 28 Å negative stain reconstructions supported by immunolabeling revealed that Mot1 
adopts an elongated shape with N-terminal TBP-binding thumb followed by a large globular 
domain corresponding to the ATPase portion at the C-terminus (hereafter referred to as 
Mot1CTD). A more detailed picture of the Mot1–TBP complex organization was revealed after 
the crystal structure of the N-terminal domain of Encephalitozoon cuniculi Mot1’s ortholog 
(Mot1NTD, residues 1–778) in the complex with full-length TBP solved at 3.1 Å resolution 
was published by the Hopfner group [47]. The crystal structure confirmed previous structural 
predictions [43] and showed that the N-terminal part of Mot1 consist of an elongated stretch 
of α-helices organized in an array of HEAT (Huntingtin, elongation factor-3, protein 
phosphatase 2A, lipid kinase TOR) repeats (Figure 1). Acidic loops of the HEAT repeats 4 
to 6 were shown to bind to the convex surface of TBP, while a “latch” loop,  
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Figure 1. Crystal structure of the Encephalitozoon cuniculi Mot1NTD–TBP complex.  
(A) The crystal structure of the E. cuniculi Mot1NTD–TBP “product” complex reported to 3.1 Å resolution [47]. 
TBP is shown in blue. The HEAT repeats of Mot1NTD are shown in yellow, annotated as HR and numbered 
accordingly. Non-HEAT repeat parts, including the insertion domain and last C-terminal helix of the crystallized 
construct are shown in orange. The latch region is shown in magenta. N- and C-terminal ends of the Mot1NTD 
construct are annotated as N and C, respectively. (B) Domain organization of the full-length E. cuniculi Mot1 
visualizing the boundaries of the crystallization construct comprising the residues 1–778 (marked in green). 
RecA1 and RecA2 subdomains of Mot1CTD are represented in pink and purple, respectively. The color code of 
the rest is as in (A). 
 
protruding from between the HEAT repeats 2 and 3, was shown to shield the TBP’s concave 
site. Additional biochemical characterization of Mot1∆latch and Mot1NTD∆latch mutants (∆97–
131) showed that the latch does not only shield TBP’s concave site preventing from TBP’s 
re-association with DNA. The latch, apart from being an important structural element, was 
found to be required for the TBP-stimulated Mot1’s ATPase activity [47]. In addition, 
deletion of the latch region impaired Mot1’s ability to dissociate TBP–DNA complexes in an 
ATP-dependent reaction, thereby proving a suggestion for its important role in the 
dissociation mechanism [47]. Moreover, Mot1 binding site to TBP clearly overlaps with the 
TFIIA binding site [47]. Thus, the structural data also explained the antagonistic effect of 
Mot1 and TFIIA [8], [44], and supported the hypothesis that Mot1 could form distinct PICs 
functionally replacing some GTFs [29], [34], [33].  
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2.1.4 Underlying molecular mechanism of Mot1 action 
 
Mot1 is a Swi2/Snf2 family member 
Based on the conserved motifs that are involved in coupling of nucleoside triphosphate 
(NTP) binding and hydrolysis to their DNA- and RNA-related functions, helicase-like 
proteins are classified into six superfamilies (SF1–SF6), which can be further divided into 
distinct families [51], [52]. As shown in Figure 2, Mot1 is a member of the Swi2/Snf2 family 
(Switching defective/Sucrose nonfermenting 2), forming a large and diverse class of proteins 
within the SF2 supefamily. A more detailed phylogenomic classification of the Swi2/Snf2 
members, based on the similarities within the conserved motifs and the presence of 
family-specific insertions, additionally distinguishes 24 distinct subfamilies [52]. The 
differences among some groupings are apparent e.g. in requirements for the stimulation of 
the ATPase activity [53].  
Swi2/Snf2 enzymes play important roles in various basic cellular processes like DNA 
replication, recombination, repair and transcription. Although Swi2/Snf2 enzymes very often 
act as multiprotein assemblies, some Swi2/Snf2 family members are fully active without any 
additional subunits, e.g. Chd1 [54], Rad54 [55] or Mot1 [8]. Many prokaryotic and archaeal 
relatives are also found among Swi2/Snf2 enzymes, e.g. Escherichia coli RapA [56] or 
Sulpholobus solfataricus Rad54-like protein [57]. Common feature of all SF2 members is the 
presence of a conserved catalytical core consisting of two subdomains that each resembles 
the fold of recombination protein RecA with characteristic helicase-related functional motifs 
mentioned above [58]. In addition, each member possesses auxiliary domains that confer the 
specificity of the RecA-like domains for particular function or substrate. Mot1 functional 
ATPase portion is required for efficient Mot1–TBP–DNA complex formation and its 
dissociation in vitro [9], [47], [59]. Moreover, Walker A or B mutants as well as deletion of 
Mot1CTD show dominant-negative phenotype in yeast [9]. Interestingly, despite high 
sequence conservation within the ATPase region of Swi2/Snf2 members, swapping of this 
region between the family members has been shown to carry the properties of the remodeling 
complex with it [60]. For example, Mot1–Snf2 and Mot1–Iswi chimeric proteins do not 
support Mot1’s function in vivo, although they bind to TBP both in vitro and in vivo [45]. 
This clearly shows that the Swi2/Snf2 motor domain is essential and contains  
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Figure 2. Classification of helicase-like proteins. 
Classification of putative helicases into superfamilies, families and subfamilies performed on the basis of 
primary structure analyses [51], [52]. Dotted box highlights the subfamily which members of are not found 
among eukaryotes. The figure is adopted from [52]. 
 
residues that are important for the specific action of each family member. 
 
Mot1 does not appear to remodel nucleosomes 
Chromatin remodelers are the largest and the best characterized group of Swi2/Snf2 ATPases 
to date, including SWI/SNF chromatin remodeling complex and its Swi2/Snf2 catalytic 
subunit, the prototype family member. Chromatin remodelers are multisubunit assemblies 
with combined molecular weights in the megadalton range, which are able to alter the 
chromatin structure, thereby enabling transcription factors and RNA polymerase to access the 
transcription start sites [61]–[63]. Chromatin remodelers act in response to DNA and histone 
modifications catalyzing nucleosome sliding in cis, transfer in trans, disassembly as well as 
histone variant exchange [64].  
Consistent with the observation that many Mot1-related enzymes are involved in 
regulating chromatin structure in some way, Mot1—independently of its TBP recruitment—
was suggested to play a direct role in nucleosome remodeling at GAL1 promoter [69]. 
However, the chromatin structures at the URA1 promoter in WT and Mot1-depleted cells 
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tested by another group were indistinguishable [34]. Moreover, Mot1- and 
TBP-immunodepleted yeast chromatin samples were shown to be deprived of 
nucleosome-size fragments [28]. Therefore, the hypothesis that Mot1, apart from TBP-related 
functions, directly affects nucleosome positioning has not been well supported so far. Next to 
Mot1, there are other examples of Swi2/Snf2 enzymes which function is not directly related 
to chromatin, e.g. Cockayne syndrome protein B, CSB (transcription-coupled DNA repair 
[65]), Rad54 (DNA recombination [66]), Rad 16 (nucleotide excision repair [67]) or RapA 
(recycling of stalled RNA polymerase in E. coli [68]). 
 
Swi2/Snf2 enzymes translocate along a DNA track 
Considering the initial classification of Mot1 as a DNA helicase-like protein [10], 
ATP-driven helicase activity leading to the promoter DNA unwinding was among the first 
proposed mechanism by which Mot1 could catalyze the displacement of TBP from DNA. For 
example, ATP-dependent disruption of TBP–DNA complexes was tested on DNA substrates 
covalently crosslinked either in the TATA box or in the upstream DNA region [46], [70]. 
However, neither full-length Mot1 nor Mot1CTD manifested strand displacement activity, with 
and without TBP [8], [46]. Importantly, although many enzymes among SF2 helicase-related 
proteins are indeed bona fide helicases, none of the Swi2/Snf2 family members has been 
demonstrated to possess a helicase activity so far. 
Despite all the efforts to unravel the molecular basis of ATP-dependent remodeling, it 
is not entirely clear what mechanisms are employed by Swi2/Snf2 ATPase motors to couple 
NTP binding and hydrolysis to protein–DNA conformational changes. However, DNA 
length-dependent ATPase activity measurements and triplex displacement activity assays 
suggest that chromatin remodelers, similarly to some other SF2 enzymes, translocate along 
dsDNA [71]–[73]. Moreover, translocase activity of bona fide helicases can be physically 
uncoupled from their strand separation activity [74], further supporting the possibility that 
Swi2/Snf2 enzymes could exploit translocation as the principal mechanisms. In this process, 
the phosphate backbone is used as a track in a relatively unspecific manner. For the prototype 
dsDNA tracking SF2 enzyme, EcoR124I, modifications or discontinuities on the 3'–5' strand 
result in more severe inhibition of translocation than those on the 5'–3' strand [75]. Although 
contacts to the 5'–3' strand are not essential for motion, they do play a key role in stabilizing 
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the motor on the DNA. Importantly, nucleosome remodeling assays using nicked and gapped 
DNA substrates showed that the translocation catalyzed by some Swi2/Snf2 members also 
predominantly occurs along the 3´–5´ DNA strand [71], [72]. Moreover, both chromatin 
remodeling complexes and their isolated catalytical subunits are active on ssDNA substrates 
[71], [73]. These findings fully support a model in which the SF2 motor contacts are 
maintained mainly by one strand of the duplex.  
A detailed idea about how Swi2/Snf2 enzymes might function is mainly based on the 
high-resolution structural information available for SF1 and other SF2 helicases, which are 
much better characterized than the Swi2/Snf2 family. Unfortunately, only few structures of 
the Swi2/Snf2 ATPase domains are available (Figure 3A). These include: a) S. solfataricus 
Rad54-like Swi2/Snf2 ATPase portion in complex with dsDNA [76]; b) chromodomains and 
ATPase portion of S. cerevisiae Chromodomain helicase DNA-binding protein 1 (Chd1) 
crystallized in the presence of ATPγS (AGS) [54]; c) Danio rerio Rad54 Swi2/Snf2 ATPase 
domain [77]; and d) full-length E. coli RapA [78]. In the first two of the four mentioned, the 
Swi2/Snf2 motor domains were trapped in inactive conformations, which—according to the 
related SF2 enzymes—would not support proper formation of the ATP binding cleft [79]. In 
other two structures, the ATPase domains adopted fully closed conformation, but neither 
DNA nor ATP analog were co-crystallized. Thus, no novel insights into e.g. molecular 
mechanism of dsDNA tracking or the role of the family-specific protrusions were revealed.  
Still, the limited structural information provides valuable information linking the 
molecular mechanism applied by Swi2/Snf2 family with these applied by other SF2 
enzymes. Remarkably, when superimposed via their N-terminal RecA folds, the DNA duplex 
bound to the SsoRad54-like protein overlays very well with dsRNA bound to the innate 
immunity sensors Rig-I [80] and MDA5 [81]. These dsRNA-activated SF2 members, 
similarly to Swi2/Snf2 enzymes, do not robustly unwind nucleic acid substrates and have 
been shown to translocate along dsRNA [82]. Further analysis shows that the ssDNA 3’ 
overhang generated by NS3 and VASA, bona fide SF2 helicases, as well as PcrA [83], a SF1 
bona fide helicase, overlays with the 3'–5' strand of the dsDNA bound to SsoRad54-like 
protein (Figure 3C). Thus, the comparative analysis of the available data implies that 
Swi2/Snf2 family members are likely to use similar mechanism as other SF2 helicases and 
translocases. 
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Figure 3. Crystal structures of nonbacterial Swi2/Snf2 ATPase domains.  
(A) Crystal structures of Swi2/Snf2 domains. From left: S. solfataricus Rad54-like–DNA complex in an 
“open” conformation [76], S. cerevisiae Chd1 in an autoinhibited “semi-closed” conformation [54] and D. rerio 
Rad54 in a “closed” conformation [77]. PDB accession codes are listed. The structures are oriented with respect 
to the RecA1 subdomain. Relative orientations of the core RecA 1 (pink) and 2 (purple) subdomains joined by a 
short linker are represented by the black arrows. Family-specific insertion regions, i.e. protrusions 1B and 2B, 
linker region as well as C-terminal are indicated in blue. The location of AGS bound in the Chd1 structure is 
indicated by the red arrow. Auxiliary domains were omitted. (B) Schematic representation of the subdomain 
organization of a Swi2/Snf2 domain. Nucleotide molecule binds at the interface formed by core subdomains 1A 
and 2A [79]. Color code is as in (A). (C) In the S. solfataricus Rad54-like protein structure, the N-terminal 
RecA subdomain recognizes both DNA strands along the minor groove and the DNA retains essentially B-form 
conformation. The 3’–5’ strand of the DNA duplex occupies a position that is virtually identical to the 3’–5’ 
overhangs in the crystal structures of related SF2 helicases (see text). The black arrows show the direction (3’–
5’) in which ATPase domain is thought to translocate along DNA. Panel (C) was adapted from [84]. 
 
 
Mot1 and DNA tracking 
Consistent with the data available for other SF2 enzymes, DNA tracking was proposed as a 
mechanism which could be also applied by Mot1 [85]. In this scenario, the presence of the 
HEAT repeat region would for example enable Mot1 to store the elastic tension generated 
during translocation process and to push or pull off TBP from the promoter DNA [47]. 
Consistent with the fact that Mot1CTD forms primary contacts to the TATA-box containing 
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strand [59] and a typical 3’–5’ translocation of SF2 enzymes [71], [72], [75], it seems that the 
“pulling off” would be a more imaginable possibility [86]. 
A very elegant study including EMSA and DNase I footprinting experiments clearly 
showed that Mot1-catalyzed disruption is not blocked by the presence of heterologous 
DNA-binding proteins preventing the Mot1–TBP–DNA complexes from falling off the ends 
of linear DNA substrates [85]. Therefore, the release of TBP from DNA by Mot1 does not 
appear to involve highly processive ATP-dependent DNA tracking over long distances. 
However, in the same study it was shown that Mot1 was able to transfer from TBP–DNA 
complex to another one localized in the upstream direction [85]. Interestingly enough, this 
occurred in the absence of ATP and was not observed when the second TATA box was 
localized downstream from the preloaded Mot1–TBP–DNA complexes. This process was 
dependent on an unobstructed path between the TBP–DNA complexes, suggesting that Mot1 
could indeed slide along DNA. However, observed results might be explained by DNA 
looping. Therefore, although a direct clear proof for DNA translocation for Mot1 has not 
been shown experimentally, current data certainly do not exclude short-range, nonprocessive 
tracking.  
 
Mot1 utilizes a DNA “handle” 
Full-length S. cerevisiae and E. cuniculi Mot1 have no specific DNA binding affinity, 
regardless of the presence or absence of ATP [8], [46], [47], [70], [87], [88] and, 
consequently, their ATPase activity is not stimulated by DNA alone [9], [46], [47]. Similarly, 
human BTAF1 binds DNA very weakly in the absence of TBP [14]. In contrast, stimulation 
of yeast and E. cuniculi Mot1’s ATPase activity occurs in the presence of TBP [45], [46]. 
Unlike its fungal orthologs, human BTAF1 is not stimulated by TBP at all, but by a 
synergistic action of TBP and DNA [14]. These differences between Mot1 orthologs are not 
well understood, however. DNA alone can activate BTAF1 to some extent, but this activity 
comprises only 1% of the activity reported in the presence of both TBP and DNA [14]. E. 
cuniculi Mot1 exhibits somewhat mixed behavior, since it shows higher stimulation by TBP–
DNA complexes than only by TBP [47].  
Absence of the DNA-dependent stimulation of Mot1 ATPase activity is at odds with 
the data which has been accumulated for many Swi2/Snf2 ATPases showing robust DNA 
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binding and DNA-dependent stimulation [53]. However, yeast Mot1CTD does bind dsDNA on 
its own and this interaction is nucleotide-dependent [88]. In the presence of TBP–DNA 
complexes, Mot1CTD was shown to protect the “upstream” (5’ end according to the TATA 
box-containing strand) region of DNA in DNase I footprinting experiments [8], [59], [70] 
and to directly interact with it in DNA–protein photocrosslinking experimens [9] as well as in 
FeBABE-mediated hydroxyl radical cleavage assay experiments [47]. Additionally, 
biochemical experiments are fully supported by structural data suggesting that E. cuniculi 
Mot1CTD localizes to the upstream DNA [47]. However, Mot1 does not have an upstream or 
downstream DNA fragment requirement for complex formation per se [70], [87]; however, 
the presence of the upstream DNA increases the stability of Mot1–TBP–DNA complexes in 
vitro [70], [87]. Moreover, although one study has shown no 5’ DNA requirement for Mot1–
TBP–DNA complex dissociation [87], other independent experiments including EMSA [8], 
[70], [88], DNase I footprinting [59] and fluorescence anisotropy [88] argue that the 
upstream region in critical for the Mot1-dependent catalysis. On the contrary, 
promoter-flanking regions in the 3' direction from the TATA box are dispensable for Mot1 
action [8], [70]. No sequence specificity has been reported so far for the formation of stable 
Mot1–TBP–DNA complexes or for their disruption. Interestingly, however, not all TBP–
promoter DNA substrates bind Mot1 with the same efficiency in direct comparison studies, 
pointing towards the possibility that base specificity may somehow contribute to the affinity 
[8], [59].  
In a very elegant FRET (Förster resonance energy transfer)-based approach, it was 
shown that the upstream DNA provides a grip mediating conformational changes introduced 
by Mot1CTD, probably propagating them towards TBP [88]. First, the alterations of the 
upstream DNA conformational changes being a direct result of Mot1CTD action could be 
transferred towards TBP initiating the changes in the TBP–promoter DNA interaction. Next, 
ATP binding could alter the interaction between Mot1CTD and the upstream DNA. Finally, 
ATP hydrolysis could trigger another conformational change, for example including 
short-range DNA translocation, which would result in the dissociation of the complex [88]. 
This model, however, cannot explain why Mot1 is able to unbend DNA independently of the 
upstream DNA [88], to dissociate TBP from DNA substrates which lack upstream DNA [87] 
or why Mot1NTD dissociates TBP–DNA complexes in the absence of Mot1CTD [47]. Finally, 
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the introduction of single nucleotide gaps in either strands of the upstream DNA has no effect 
on the ATP-dependent dissociation [70] and Mot1 can efficiently dissociate TBP from highly 
constrained minicircle DNA substrates [70]. Thus, the upstream DNA “handle” and the TBP–
DNA complex appear to be conformationally uncoupled.  
 
Mot1 might directly impact TBP or TATA-box DNA conformation  
EMSA experiments performed on I–C (inosine–cytosine)-substituted DNA substrates and 
unmodified TATA boxes revealed that although Mot1 bound all TBP–DNA substrates with 
the same affinity, modified nucleic acids did not efficiently support the Mot1-dependent 
catalysis upon ATP addition [45]. Interestingly, Mot1 binding affects TBP’s DNA protection 
pattern in DNase I footprinting experiments [8], [70]. This raised the possibility that Mot1 
requires a direct contact with the TATA box in order to dissociate TBP–DNA complexes [45]. 
In fact, site-specific photocrosslinking of Mot1 to DNA performed in the presence of TBP as 
well as TBP’s mutagenetic studies suggested that Mot1 contacts not only upstream DNA but 
also the TATA box itself [49], [59]. However, since Mot1 is able to efficiently dissociate 
TBP–DNA–NC2 complexes, Mot1 is unlikely to require a direct contact with the TATA 
major groove [48]. 
Alternatively, Mot1 could act via affecting the TBP–promoter interaction by a direct 
influence of TBP’s conformation. The idea that Mot1 might directly influence TBP structure 
has been broadly discussed [45], [46], [48], [59], [87], [90], although there has not been yet 
any direct evidence for it. Mot1-induced alterations of TBP structure could force a state in 
which TBP would be incompetent to bind to the TATA box anymore. Mot1–TBP–DNA 
complex of altered TBP–promoter interaction could be then more easily dissociated. 
However, inducing a huge conformational change in the conserved TBP core domain seems 
to be rather unlikely. The analysis of available structural data presenting TBP in complex 
with various factors, including the Mot1NTD–TBP crystal structure, revealed that TBP 
remains in a rather similar conformation [47]. Nevertheless, Mot1 could possibly perturb e.g. 
TBP stirrups or the β-strands connecting the two subdomains [59].  
Another intriguing way to regulate DNA binding behavior of TBP and—at the same 
time—promoter DNA conformation could be regulated by a direct interaction between Mot1 
and nonconserved N-terminal tail of TBP [92]. Full-length yeast TBP was shown to form 
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complexes with promoter DNA in a two step manner, forming first unbent transient product 
of TBP sensing a TATA box-containing DNA, which then slowly formed stable, bent DNA 
complexes. The N-terminal tail of TBP was required for the formation of the unbent species. 
Additionally, mutations localized on the convex, solvent-exposed surface of the full-length 
TBP (inhibitory DNA binding surface, IDB) were shown to indirectly affect the promoter 
DNA conformation [92]. Interestingly enough, the IDB surface overlaps with the region 
recognized by Mot1 [49]. Therefore, DNA conformation could be potentially regulated 
through protein–protein contacts between Mot1 and DNA-bound TBP by promoting unbent 
DNA conformation via displacing TBP’s N-terminal tail from the IDB surface. BTAF1 does 
not interact with hTBP’s N-terminus [14], but Mot1 binds TBPcore–DNA complexes more 
strongly than DNA complexes formed on full-length TBP [8]. Moreover, the DNase I 
protection pattern of the TATA box in Mot1–TBP–DNA complexes was reported to differ for 
the full-length TBP and for TBPcore construct [59]. However, more recent single-molecule 
studies did not report the presence of the unbent TBP–DNA complexes, thereby suggesting 
simultaneous TBP binding and DNA bending [93]. 
 
 
2.2 NC2 
 
2.2.1 Discovery and function in vivo 
 
NC2 (Negative cofactor 2) was initially described by Meisterernst and Roeder as a factor 
able to change the mobility of human TBP–DNA complex in EMSA [94]. NC2 was able to 
suppress the basal level of core promoter activity in an RNA pol II transcription assay by 
blocking the association of TFIIA and TFIIB with TBP–DNA complexes [94]. Independently, 
Reinberg and co-workers isolated and cloned a TBP-interacting protein, which they called 
Dr1, manifesting influence on the transcription similar to NC2 [95]. Despite many 
similarities, recombinant Dr1—in contrast to the endogenous one—failed to form a stable 
complex with TBP and promoter DNA and did not block the formation of TBP–DNA–TFIIA 
complexes in EMSA. The observed differences could be explained by in vivo Dr1 
phosphorylation, which was shown to regulate the TBP–Dr1 interaction [95]. Further 
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experiments performed by Meisterernts and colleagues revealed that NC2 is composed of 
two subunits, subsequently named α and β, and identified Dr1 to be identical to the latter one 
[96]. Therefore, previously reported differences between the recombinant and endogenous 
Dr1 observed by the Reinberg group [95] could be explained by the lack of the associated 
subunit, NC2α (also denoted as DRAP, standing for Dr1-associated protein). To date, a 
general co-association of both subunits of the NC2 heterodimer on chromatin has been well 
documented, e.g. by ChIP data [97].  
Yeast genetic screen selecting for the suppressors of SUC2 promoter upstream 
activating sequence (SUC2∆UAS) identified the bur6-1 mutation (for Bypass UAS 
Requirement) causing large defect in the gene encoding the NC2α subunit [11], [12]. Further 
investigations have shown that NC2 heterodimer negatively regulates transcription from class 
II promoters on a global scale in vivo [98]  and that both subunits are essential for yeast cell 
viability [98]–[100]. Subsequently, NC2 was shown to play also a stimulating role on certain 
RNA pol II promoters in vitro and in vivo [26], [36], [97], [99], [101]–[105]. On a 
genome-wide scale, thermal inactivation of bur6-1 conditional mutant affects approximately 
17% of the yeast genes [101], [102].  
 
 
2.2.2 Structure  
 
N-termini of both NC2 subunits were predicted to contain a histone fold motif [106], which 
was shown to be absolutely essential for the yeast cells viability [100]. The crystal structure 
of the human NC2 heterodimer recognizing the complex of TBP bound to a 19 bp dsDNA 
containing a TATA element was published [107] (Figure 4). The structure reported to 2.6 Å 
resolution confirmed the presence of the histone fold dimerization domain and its 
resemblance to the molecular organization of the H2A/H2B heterodimer within the 
nucleosome [108] and, consequently, other histone fold-containing transcription factors, e.g. 
NF-Y complex [109], [110]. NC2 was demonstrated to “lock” TBP on the promoter between 
the histone fold domain (NC2HF) bound to the underside of the DNA and the convex 
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Figure 4. Cartoon representation of the Homo sapiens TBP–DNA–NC2 complex crystal structure solved 
at 2.7 Å resolution [107]. 
TBP is shown in dark blue. The TATA-containing DNA fragment is depicted in gray. The subunits of NC2 
heterodimer: NC2α/DRAP and NC2β/Dr1 are shown in light and dark green, respectively. The key secondary 
structure elements as well as the upstream (U) and downstream (D) side of the promoter are annotated. Helices 
H1, H2 and H3 of NC2α as well as H1, H2 and H3 of NC2β assemble into histone fold domain and bind to the 
underside of the TATA box, opposite of the TBP’s binding site. Helix H5, joined with the histone fold domain 
via helix H4, binds to the top surface of TBP, thereby locking it on the promoter DNA and blocking its 
association with GTFs. 
 
bound C-terminal helix H5 of NC2β. Thus, the localization of the NC2β's C-terminal helix 
provided the first structural explanation for blockage of TFIIB entry to PIC. Although the 
antagonistic effects of NC2 on TFIIA and TFIIB association with TBP–DNA complexes were 
shown in numerous biochemical experiments [94]–[96], [100], [102] and via 
complementation studies in yeast [100], [104], the sterical hindrance of NC2 and TFIIA 
binding was not obvious from the analyzed crystal structures [111], [112]. Eventually, 
Ebright and colleagues using a site-specific protein–protein photocrosslinking approach 
showed a sterical incompatibility between TFIIA and NC2α at TBP helix H2 in the regions 
which were omitted from the constructs used in the crystallization of TBP–DNA–NC2 and 
TBP–DNA–TFIIA complexes [113]. 
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2.2.3 NC2 alters the TBP–promoter structure 
 
DNase I footprinting experiments revealed that binding of NC2 to the TBP–DNA complexes 
influences DNA conformation [114]. Moreover, single-molecule FRET, restriction digest-
coupled electrophoretic mobility shift (RCE) and crosslinking restriction digest-coupled 
immunoprecipitation (CRIP) experiments demonstrated that NC2 repositions TBP towards 
the DNA ends [114]. Observed NC2-induced lateral mobility of TBP on DNA was proposed 
to explained how NC2, sliding TBP off the promoter regions in cis, could negatively affect 
the very first stages of transcription initiation process [114]. The same mechanism was also 
proposed to account for NC2's activation role; NC2-induced sliding could theoretically 
enable TBP’s repositioning towards the promoter sites [114]. 
 
 
2.2.4 Mot1 and NC2 play similar roles in vivo 
 
Several lines of evidence indicate that Mot1 and NC2 have related functions with respect to 
transcription in vivo (see below). For example, the bur6 mutation was identified in the same 
genetic screen as bur3/mot1 mutation and displayed the same phenotype [11], [12]. ChIP and 
mRNA level profiling of the temperature sensitive strains as well as comparison of individual 
microarray profiles have shown that Mot1 and NC2 not only interact genetically, but largely 
overlap in localization and function both in vitro and in vivo [18], [20]. For example, a study 
in which 90% of all class II genes in yeast were analyzed by ChIP-chip revealed that more 
than 97% of all Mot1-bound promoters overlap with NC2α or NC2β-bound promoters in 
exponentially growing cells [97]. Analogously, highly overlapping sets of Mot1- and 
NC2β-dependent genes, be it up- or downregulated, were shown in a direct study applying an 
anchor-away technique [26]. Consequently, NC2β-repressed genes are preferentially TATA-
enriched and SAGA-dominated, in contrast to activated housekeeping genes, which are 
TATA-less and TFIID-dependent promoters [26], [35]. In Drosophila, NC2 heterodimer next 
to Mot1 serves as general activator of DPE-dependent transcription with a TATA-specific 
repression function [36], [115]. Furthermore, the anchor-away depletion of NC2β results in 
synthetic lethality in ∆SPT7 background, thereby implicating a functional link to the SAGA 
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complex and Mot1 [26]. Some single studies, however, do not report significant correlation 
between NC2α association and TATA box on human promoters [116]. Instead, negative 
correlation between NC2 occupancy and the presence of TFIIB responsive elements (BREs) 
was found [103], [117]. 
Interestingly, the promoter association of NC2 is dramatically increased in the 
absence of functional Mot1, which would imply that these two regulators compete for the 
association with TBP or that the decreased level of Mot1 results in inefficient dissociation of 
NC2 from promoter sites [19], [118]. The latter option was supported by the results presented 
in Schluesche et al., where extremely low off-rate of the TBP–NC2 complexes from the 
promoter sites were shown in vitro [114] and by Timmers group who observed slowed 
dissociation of TBP and NC2 from HXT2 promoter in mot1-1 conditional mutant strain after 
the glucose shift [97]. Consistent with these results, Auble’s group identified a TBP mutant 
bypassing the requirement of Mot1 in vivo with greatly decreased affinity to NC2 in vitro 
[59]. Moreover, fluorescence recovery after photobleaching (FRAP) live cell imaging in 
yeast [119] and in human cells [118] showed that Mot1 regulates the release of TBP from 
chromatin. Importantly, the same method revealed that NC2 has a totally opposite effect of 
Mot1 and that combined knock-down of NC2 and Mot1 restored the dynamics of TBP to the 
level of the untreated cells [118]. Thus, Mot1 appears to function as a factor, which regulates 
the accessibility of poised TBP–NC2 complexes in the cell. 
Finally, yeast recombinant Mot1 and NC2 were able to simultaneously bind TBP–
DNA complexes in EMSA [48]. Stable Mot1–TBP–DNA–NC2 complexes were 
subsequently isolated from yeast chromatin extracts [97]. In both cases, these complexes 
were shown to be disrupted upon ATP addition. A proteomic analysis of yeast 
Mot1-associated factors also confirmed robust association of Mot1, TBP and NC2 subunits 
[120]. Although the formation of BTAF1–TBP–DNA–NC2 complexes was not observed in 
the case of human proteins [121], simultaneous binding of Mot1 and NC2 to the same TBP–
DNA complex is fully supported by the structural data [47], [107]. However, the exact 
character of Mot1–NC2 interplay is still barely understood.  
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Figure 5. Impact of Mot1 and NC2 action on gene expression. 
Transcription start site (TSS) is depicted by an arrow. The black cross (x) represents events, which lead to 
blocked transcription initiation. (A) Mot1 ejects TBP from core promoter. (B) Mot1 displaces TBP from 
inappropriate genomic locations (i.e. nonpromoter DNA) to increase free TBP pool. (C) Mot1 removes TBP 
bound in the “wrong” direction to free the promoter and allow productive TBP binding. (D) NC2 diffuses TBP 
away from the promoter. (E) NC2 diffuses TBP in the direction of the promoter. (F) NC2 sterically prevents the 
entry of GTFs like TFIIA and TFIIB. (G) Mot1 and NC2 direct the formation of alternative functional PIC 
assemblies.  
 
 
2.2.5 NC2α and NC2β may function as separate subunits 
 
Formation of TBP-containing complexes is well documented not only for the NC2 
heterodimer, but also for the separate α and β subunits. Human NC2β was shown to interact 
with TBP in EMSA [94], [106], pull-down experiments [106], [121] and in yeast two-hybrid 
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assay [106]. Moreover, formation of TBP–DNA–NC2β and TBP–DNA–NC2β–TFIIA 
complexes in EMSA was reported [94]. In contrast to the human NC2β, its yeast ortholog, 
however, did not bind TBP–DNA [22]. The TBP–NC2α interaction as well as the presence of 
TBP–DNA–NC2α–BTAF1 and TBP–NC2α–BTAF1 complexes was observed in pull-down 
and EMSA experiments [121]. Furthermore, human NC2α was reported to interact with 
BTAF1 in yeast two-hybrid assay and this interaction was dependent on the C-terminal acidic 
domain of NC2α [121]. Additional pull-down assays have shown that this interaction is not 
mediated via DNA. Interestingly, human NC2β in the absence of NC2α, although less 
efficiently that as the NC2 heterodimer, was also able to repress RNA pol II transcription in 
vitro [94], [106], [122]. Moreover, NC2α and NC2β were not found to be stably associated in 
exponentially growing yeast cells. Instead, their association followed glucose depletion after 
diauxic shift [123]. Western blot analysis of yeast WCE revealed a high molecular weight 
population of NC2β that was free of NC2α [99]. Furthermore, ChIP at selected promoters 
[123] as well as genome-wide study [97] showed differential distribution of NC2α and NC2β 
subunits upon shift to low glucose. Thus, NC2α–NC2β association seems to be regulated in 
response to environmental stress.  
 Both human NC2 subunits possess classical nuclear localization signal sequence and 
are imported to the nucleus as separate subunits or, preferentially, as a pre-assembled 
heterodimer [124]. Interestingly, only the NC2β subunit possesses a nuclear export signal 
sequence, which is masked upon the dimerization with NC2α, thereby ensuring that only 
complexed NC2β remains in the nucleus. This strongly points toward an independent role for 
NC2α in the nucleus. Importantly, phosphate-mimicking mutations of NC2β hamper its 
nuclear localization [124]. Thus, posttranslational modifications of NC2, with 
phosphorylation as one of many possibilities, could be a way of direct regulation of 
interaction between both subunits and their association with transcriptional machinery. 
Indeed, both NC2α and NC2β subunits are in vitro and in vivo substrates of casein kinase II 
[106], [121] and were found to be phosphorylated in vivo [95]. Interestingly, phosphorylation 
was shown to affect the association of NC2β with TBP [94] as well as either subunit with 
DNA [96]. Furthermore, NC2β was shown to be involved in repression of selected RNA 
pol III-transcribed genes not only in vitro [125] but also in vivo, both in yeast [99] and in 
human cells [126]. To date, there has been no evidence that NC2 affects RNA pol I-driven 
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transcription [99], [125], [126] or that NC2α has an effect on RNA pol III transcription [126]. 
 Finally, partial disruption of the recombinant human NC2 heterodimer in the presence 
of purified TBP and BTAF1-enriched lysate [121] as well as ATP-dependent dissociation of 
the NC2 heterodimer in the Mot1–TBP–DNA–NC2 complex isolated from chromatin 
extracts [97] were observed. However, how Mot1 would contribute to the regulation of 
NC2α–NC2β association remains unknown. 
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3. AIMS OF THE RESEARCH PROJECT 
 
 
Swi2/Snf2 enzymes play many important roles in various basic cellular processes like DNA 
replication, recombination, repair and transcription. Despite extensive studies, the detailed 
mechanism of Swi2/Snf2 translocation remains largely unknown. Many studies have aimed 
at understanding the mode of action of Swi2/Snf2 translocases. Nevertheless, the existing 
hypotheses are still primarily based on the results obtained for related SF1 and SF2 bona fide 
helicases and other SF2 translocases, which are much better characterized on structural level. 
In order to answer the piling up questions regarding the detailed mechanisms employed by 
Swi2/Snf2 ATPases, an atomic view at a Swi2/Snf2 remodeler in the presence of its substrate, 
DNA and nucleotide is required.  
One of the major obstacles in studying Swi2/Snf2 ATPases is the fact that most of the 
family members assemble into multisubunit complexes and act on complex protein–DNA 
substrates, e.g. nucleosomes, which make the structural analysis very challenging. Thus, it 
appears that the fundamental properties of all Swi2/Snf2 ATPases that allow these enzymes 
to accomplish their specific tasks via translocation along double-stranded DNA form at the 
same time critical barrier across the way to understand them better.  
The ultimate goal of this study was to provide a mechanistic model of the ATP-
dependent remodeling reaction employed by Swi2/Snf2 enzymes based on a hybrid structural 
characterization of Mot1, the first Swi2/Snf2 member for which biochemical activity has 
been demonstrated in vitro. Importantly for the structural analysis, the function of Mot1— 
ATP-dependent disruption of TATA box-binding protein (TBP)–DNA complexes—does not 
require the presence of any associated subunits. Therefore, Mot1 in complex with its 
relatively simple TBP–DNA substrate serves as a perfect model system for in vitro studies of 
Swi2/Snf2 translocases. 
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4. RESULTS 
 
 
4.1 Analysis of Mot1–NC2 complexes 
 
4.1.1 Gel filtration 
 
NC2 stabilizes formation of the Mot1–“substrate” complexes 
Intact Mot1–TBP–DNA–NC2 complexes can be isolated from Saccharomyces cerevisiae 
chromatin extracts [97]. Formation of the Mot1–TBP–DNA–NC2 complex and its 
ATP-dependent disruption was also shown in EMSA performed on the recombinant yeast, 
but not the human proteins [48], [121]. Thus, the ability of Mot1 and NC2 to form stable 
complexes on DNA-bound TBP was tested on the Encephalitozoon cuniculi proteins.  
TBP–NC2 complexes were shown to have limited specificity for TATA DNA 
sequences [127]. Similarly, Mot1-associated TBP does not discriminate between TATA and 
non-TATA DNA [49], [87]. Therefore, in order to ensure homogeneous binding, DNA 
substrates used in this test always contained TATA box consensus sequence (5´–
TATAAAAG–3´). As shown in Figure 6 (black lines), stable E. cuniculi Mot1–TBP–DNA–
NC2 and Mot1NTD–TBP–DNA–NC2 complexes could be efficiently formed in the presence 
of TATA-containing dsDNA and could be separated from the subcomplexes (e.g. TBP–DNA–
NC2 complexes) and single protein or DNA components by size exclusion chromatography. 
In contrast, Mot1–TBP–DNA and Mot1NTD–TBP–DNA complexes were much less stable in 
gel filtration (Figure 6, gray lines). Of note is that the formation of the full-length 
Mot1-containing complex was not affected by the presence of nonhydrolyzable ATP analogs 
or ADP. Formation of the NC2-containing complexes was also not affected by the presence 
of the latch region; Mot1 and Mot1NTD constructs supported complex formation as efficient as 
Mot1∆latch and Mot1NTD∆latch mutants (not shown). This was unexpected, since the latch region 
was shown to be responsible for ATP-independent disruption of TBP–DNA complexes [47]. 
Additionally, the formation of Mot1–TBP–DNA–NC2 and Mot1NTD–TBP–DNA–NC2 
complexes was found to be strictly DNA-dependent. Although Mot1NTD co-eluted with TBP 
and NC2 in the absence of DNA, full-length Mot1 bound only TBP (Figure 7).  
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Figure 6. NC2 stabilizes the Mot1–TBP–DNA and Mot1NTD–TBP–DNA complexes in size exclusion 
chromatography. 
(A) Top: elution profiles of Mot1–TBP–DNA (gray) and Mot1–TBP–DNA–NC2 complexes (black) obtained in 
gel filtration experiments. Absorbance at 260 nm and at 280 is shown as dashed and solid lines, respectively. 
Bottom: analysis of the fractions by SDS-PAGE (Coomassie staining) and agarose gel electrophoresis (Gel-Red 
staining . (B) Same as (A) is shown for the Mot1NTD construct. 
 
Taken together, the addition of the NC2 subunits greatly increased the stability of 
DNA-containing complexes in the gel filtration. Therefore, NC2 was included in most of the 
crystal setups, which greatly contributed to the successful finalization of the crystallization 
experiments (see below). 
 
NC2β interacts with Mot1 in a TBP-dependent manner in the absence of DNA 
The ability of separate α and β subunits of NC2 heterodimer to form various TBP-containing 
complexes has been shown both for human and yeast orthologs [94], [106], [121]. Thus, the 
ability of NC2β to form alternative complexes in gel filtration chromatography was 
investigated. Experiments testing the ability of NC2α to form adequate complexes 
unfortunately could not be performed, since this subunit of the E. cuniculi heterodimer could 
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Figure 7. Gel filtration analysis of Mot1–TBP–NC2 and Mot1NTD–TBP–NC2 complexes in the absence of 
DNA.  
(A) Top: in gel filtration experiments, NC2 is not able to interact with Mot1 or Mot1–TBP complex in the 
absence of DNA. Absorbance at 280 nm is shown. Bottom: analysis of the fractions by SDS-PAGE (Coomassie 
staining). (B) Analogous analysis of the Mot1NTD construct shows weak interaction between Mot1NTD, TBP and 
NC2 in the absence of DNA. The approximate molecular weights of the complexes were estimated empirically 
by calibration of the columns with gel filtration protein standard. The peaks corresponding to higher-order 
Mot1NTD–TBP complexes (*) and NC2β (**) are marked. Molecular weight of the E. cuniculi Mot1, Mot1NTD, 
TBP, and NC2β is 144, 89, 22 and 17 kDa, respectively. 
 
not be express solubly. As already discussed, the NC2 heterodimer was not able to form 
complexes with Mot1 and TBP in the absence of DNA (Figure 7). Interestingly however, the 
NC2β subunit readily formed complexes with Mot1NTD or Mot1 and TBP (Figure 8). 
Moreover, the formation of the NC2α-deprived complexes in gel filtration was strictly 
dependent on the presence of TBP, since no Mot1–NC2β and Mot1NTD–NC2β complexes 
could be detected. Interestingly, Mot1–TBP–NC2β complexes were present in two distinct 
“monomeric” and “dimeric” forms (Figure 8B), whereas Mot1NTD–TBP–NC2β complexes 
formed only “dimers”. The Mot1NTD construct is known to form dimers in solution ([47] and 
Figure 7B), but multimeric species of the full-length Mot1 have not been detected. The 
transition between those states was not affected by the presence of magnesium and other 
divalent cations (zinc, calcium and manganese), ADP, AGS, different salt conditions, 
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Figure 8. Gel filtration analysis of Mot1–TBP–NC2β and Mot1NTD–TBP–NC2β complexes. 
(A) In contrast to the results shown in Figure 7, Mot1 and NC2β form ternary complex in the presence of TBP 
(peak I and II). (B) Further analysis of peaks I and II, which were re-run on an analytical gel filtration column, 
suggests the presence of equilibrium between “monomeric” (peak II) and “dimeric” (peak I) Mot1–TBP–NC2β 
species. (C) Analogously to the full-length Mot1, the Mot1NTD construct forms Mot1NTD–TBP–NC2β but not 
Mot1NTD–NC2β complexes. Panel (D) shows that Mot1 does not efficiently associate with NC2β in gel filtration 
in the absence of TBP. The approximate molecular weights of the complexes were estimated empirically by 
calibration of the columns with gel filtration protein standard. The peaks corresponding to higher-order 
Mot1NTD–TBP complexes (*) and NC2β (**) are marked. The fractions were analyzed by SDS-PAGE 
(Coomassie staining). Molecular weight of the E. cuniculi Mot1, Mot1NTD, TBP, and NC2β is 144, 89, 22 and 
17 kDa, respectively. 
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presence/absence of a reducing agent or the order of mixing the components before gel 
filtration (not shown). Instead, these two forms appeared to persist in dynamic 
monomer/dimer equilibrium likely depending on the sample concentration. 
Taken together, the initial experiments performed on the E. cuniculi proteins show 
strong interaction between the NC2β subunit and Mot1–TBP complex in the absence of the 
associated NC2α subunit. This is of potential interest, since separate role for NC2α and NC2β 
in transcription regulation has been proposed (see section 2.2.5). However, adequate Mot1–
TBP–NC2β complexes were not detected for human proteins [121] and not tested yet on 
yeast orthologs.  
 
 
4.1.2 Electrophoretic mobility shift assay (EMSA) 
 
NC2β does not substitute for NC2 in DNA-containing complexes 
Given the fact that NC2β could efficiently incorporate into Mot1–TBP–NC2β complexes, the 
ability of NC2β to form DNA-containing complexes was tested. Human NC2β has been 
reported to form TBP–DNA–NC2β complexes in EMSA and to repress RNA pol II 
transcription in vitro [94], [106], [122]. In comparison to its human ortholog, the yeast NC2β 
could not form TBP–DNA–NC2β complexes [22].  
 
 
Figure 9. The NC2β subunit does not bind TBP–DNA complex in the absence of NC2α.  
(A) NC2 readily forms ternary complexes with TBP and DNA in EMSA (**). (B) NC2β does not bind to TBP 
and DNA under the same conditions and in the same concentration range. Only TBP–DNA complexes are 
observed (*). To enable visualization of the DNA-bound complexes, 5’-FAM-labeled 42mer TATA dsDNA was 
used in both experiments. 
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As shown in Figure 9, E. cuniculi NC2β was unable to bind to TBP–DNA. In gel 
filtration, the addition of Mot1 did not rescue the disability of NC2β to form the complex 
(not shown). This demonstrates that the presence of NC2α subunit is required to form TBP–
DNA–NC2 and Mot1–TBP–DNA–NC2 complexes in the E. cuniculi system, whereas NC2β 
associates with Mot1 in the absence of DNA. Thus, the E. cuniculi orthologs again behaved 
differently to the human and similarly to their yeast relatives. This might point towards 
functional differences between human and fungal proteins.  
 
 
 
4.2 X-ray crystallographic analysis of the Mot1NTD–TBP–DNA–NC2 
complex 
 
4.2.1 Crystallization and structure determination 
 
The structural bases of the final product state of Mot1-catalyzed reaction, i.e. Mot1–TBP 
interaction have been described previously [47]. In order to gain structural information about 
how Mot1 engages TBP and DNA before the remodeling reaction takes place, various 
crystallization experiments were performed. Homogeneous samples of E. cuniculi Mot1–
TBP–NC2 complexes in the presence of different TATA box-containing DNA substrates of 
various lengths and including all available Mot1 constructs (Mot1, Mot1∆latch, Mot1NTD, and 
Mot1NTD∆latch) were screened for the ability to form crystals or crystalline precipitate. The 
Mot1NTD portion (residues 1–778) and TBP (full-length) used in this study had exactly the 
same residue boundaries as the construct which has been used in previous studies [47] but 
lacked the N-terminal His6-tag, which was cut off during the purification process thanks to 
the introduction of TEV protease recognition site. Full-length NC2β subunit also possessed a 
cleavable N-terminal His6 tag, whereas NC2α subunit was untagged. 
 All the attempts to obtain crystals of the ensembles containing Mot1CTD, also in the 
presence of different nucleotides, e.g. ADP, AGS, and ABF, were not successful. After 
extensive screening, the Mot1NTD–TBP–DNA samples after long incubation times (up to 
several weeks) in some cases led to Mot1NTD–TBP crystals, confirming the inherent 
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instability of the ternary complex observed in the gel filtration experiments. In contrast, in 
the presence of NC2 and only for a specific subset of DNA substrates (see Table 13 and 14) 
Mot1NTD–TBP–NC2–DNA and Mot1NTD∆latch–TBP–DNA–NC2 complexes crystallized 
together (Figure 10). Both complexes exhibited almost identical preference for the crystal 
growth conditions. However, shorter DNA samples (14 bp) did not support the 
NC2-dependent complex stability and, again, the Mot1NTD–TBP crystals were obtained. The 
presence of the DNA in the crystals could be effectively assessed based on the strength of 
light polarization properties (Figure 10B). 
 
 
Figure 10. Results of the crystallization experiments. 
(A) Initial crystals of E. cuniculi Mot1NTD∆latch–TBP–DNA–NC2 complex forming numerous small plate 
clusters. (B) Crystal morphology in condition shown in (A) after optimization. The picture was taken using a 
polarization filter. (C) Crystals of the selenomethionine-derivatized E. cuniculi Mot1NTD–TBP–DNA–NC2 
complex obtained in the course of streak seeding experiments. (D) View of the streak-seeded crystals grown in 
the condition used for the actual data collection (0.2 M imidazole malate pH 5.1 and 11% PEG4000). 
 
Several hundred of Mot1NTD∆latch–TBP–DNA–NC2 and Mot1NTD–TBP–DNA–NC2 
complex crystals originating from different crystallization conditions were screened for X-
ray diffraction. Majority of the crystals diffracted to a limited resolution of 5 to 8 Å and were 
often characterized by “streaky”, poorly-defined reflections. The length of the DNA used had 
a great impact on the ability to obtain crystals, pointing out at possible involvement of DNA 
in the formation of the crystal contacts. Therefore, different lengths and variations of the 
overhangs were incorporated into the screening in order to find a DNA substrate improving 
crystal morphology and diffraction quality (listed in detail in Table 13 and 14). Additionally, 
different pre- and post-crystallization treatments like crystal annealing, glutaraldehyde 
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crosslinking, dehydration [128] or lysine methylation [129] were applied. However, none of 
these methods showed any improvement in diffraction quality and, therefore, they are not 
described here in detail. Moreover, in order to test whether the cryocooling conditions 
negatively affect crystal diffraction, data collection at room temperature was performed but 
again, no difference in diffraction at room temperature and at 100 K was observed as well. 
 Finally, three crystals of the selenomethionine-derivatized Mot1NTD–TBP–DNA–NC2 
complex diffracting below 4.5 Å were found. Selenomethionine incorporation is a standard 
method for introducing heavy atoms to protein crystals (for Se, Z=34) [130]. In principle, 
selenomethionine has similar properties to methionine (Z=16), like volume and shape. This 
method facilitates not only experimental phase determination in crystallography by single- 
(SAD) or multiwavelength anomalous dispersion (MAD). The presence of selenium atoms 
often changes protein hydrophobicity it is possible that selenomethionine-derivatized protein 
crystals can be obtained even if no native crystals are present. It is, therefore, possible that 
selenomethionine derivatization directly contributed to the improved diffraction of the 
crystals. However, most of selenomethionine-derivatized Mot1NTD–TBP–DNA–NC2 
complex crystals still diffracted poorly.  
 A data set extending to 3.8 Å resolution was collected from a crystal formed using the 
Mot1NTD–TBP–DNA–NC2 complex sample containing a 24 bp dsDNA oligonucleotide (5’–
AGTAGGGCTATAAAAGGGGGTGGC–3’, top strand). Unfortunately, the absorption 
spectrum of selenium atoms was not recorded due to technical problems at the beamline. 
Therefore, the data set was collected at the theoretical wavelength of K absorption edge of 
selenium (λ=0.9794 Å). The complex crystallized in the space group C 1 2 1 (a=150.6 Å, 
b=140.3 Å, c=90.8 Å, α=90.0°, β=113.7°, γ=90.0°) with 60% solvent content and one 
complex per asymmetric unit.  
 The structure was successfully solved by the molecular replacement method using E. 
cuniculi Mot1NTD and TBP molecules from the Mot1NTD–TBP complex crystal structure as 
well as human TBP–DNA–NC2 complex crystal structure as initial models [47], [107]. 
Unambiguous density interpretation, particularly helpful in defining side chains positions, 
was achieved using real space-based electron density modification method like solvent 
flattening using PARROT [131], [132] as well as modified 2 Fo – Fc maps using B-factor 
sharpening and Feature Enhanced Map (both implemented in PHENIX [133]). Solvent 
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flattening method exploits the fact that average electron density of protein and solvent 
regions are different [134]. After the solvent and protein region masks are defined, the 
electron density of solvent region is set to a constant value and new structure factors are 
computed. Finally, the newly obtained phases are combined with the original ones and 
improved map is obtained. B-factor sharpening is also a very useful tool for the enhancement 
of low resolution maps [135]. It is a resolution-dependent weighting function applied to a 
particular electron density map. Adjusting the B-factor results in up-weighting of higher 
resolution terms and, therefore, increases detail for higher resolution features such as side 
chain conformations. Feature enhanced map is a modified 2Fo – Fc map which i.a. exploits 
the advantages of composite residual OMIT maps, B-factor sharpening and histogram 
equalization [133]. FEM maps are characterized by reduced noise and bias and eliminate the 
need to choose and arbitrary map contouring cutoff.  
Applied density modification methods enabled de novo chain tracing of the very 
N-terminal region of Mot1 HEAT repeat domain (i.e. first 40 amino acids comprising helix 
H1 and H2 of HR1 as well as helix H3 of HR2) which had different sequence register than 
reported for the E. cuniculi Mot1NTD–TBP crystal structure (Figure 11). The difference in the 
electron density quality between the two structures was likely a result of the crystal packing. 
In the Mot1NTD–TBP–DNA–NC2 crystal structure reported here, the very N-terminus of  
 
 
Figure 11. Shift in the sequence register between Mot1NTD in Mot1NTD–TBP crystal structure [47] and 
Mot1NTD–TBP–DNA–NC2 crystal structure.  
Left: Assignment of the secondary structure for the first 50 amino acids of Mot1NTD in Mot1NTD–TBP crystal 
structure (top, yellow) and Mot1NTD in Mot1NTD–TBP–DNA–NC2 crystal structure (bottom, orange). Right: 
superimposition of the first 50 amino acids shows that in the Mot1NTD–TBP–DNA–NC2 N-terminus of Mot1NTD 
adopts more α-helical structure. 
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Mot1 is largely engaged in the crystal contact formation and the density of this region is well 
defined despite relatively low resolution. In contrast, the packing of the Mot1 N-terminus in 
the Mot1NTD–TBP crystals was unfavorable. Additionally, the electron density of this region 
is very poor, even despite moderate resolution (3.1 Å). 
Owing to poor diffraction, the anomalous signal of selenomethionine atoms did not 
allow the experimental phasing. Nevertheless, computing the anomalous difference map 
(using FFT, part of CCP4 suite [131]), which shows the positions of anomalous scatterers, 
was used for unambiguous assignment of the selenomethionine side chains. This was 
particularly important in the case of NC2α and NC2β polypeptide chains, since the side 
chains of the histone fold part of NC2 were omitted from the model owing to poor electron 
density map quality of this region. However, anomalous difference density peaks (up to 5σ) 
were present in some cases (Figure 12B). Final model of the Mot1NTD–TBP–DNA–NC2 
crystal structure is characterized by Rwork/Rfree of 23.5/25.8% (according to BUSTER) and 
good stereochemistry (Table 1).  
 
Figure 12. X-ray electron density maps. 
(A) 2Fo – Fc electron density map of DNA bases displayed at 1σ contour level (gray mesh). TBP is additionally 
shown in blue. For clarity, electron density of the protein chain is not shown. The widening at the TATA box is 
nicely visible even at low resolution (marked with the arrow). (B) Weak anomalous signal of selenium atoms 
contoured at 4σ (gray mesh). Four out of seven (NC2β, top) and two out of five (NC2α, bottom) 
selenomethionine sites could be identified by this approach confirming the sequence register. 
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Table 1. Data collection and refinement statistics.  
Equations defining R-values are standard and hence not defined.  
 
Data collection    Refinement   
Space group C 1 2 1  Resolution (Å) 49.17–3.8  
Cell dimensions   Rwork/Rfree (%)** 23.5/25.8(26.9/30.2)  
 
 
    a, b, c (Å) 150.6, 140.3, 90.8    No. atoms   
    α, ß, γ (°)  90.0, 113.7, 90.0      Protein 8422  
Resolution (Å) 49.17–3.8 (4.0–3.8)*      DNA 799  
No. reflections       Ligand/ion 0  
    All 108074      Water 0  
    Unique 17163  Isotropic B-factors   
R merge (%) 10.4 (78.9)      Protein 69  
CC(1/2) 99.8 (83.8)      DNA 135  
I/σI 7.5 (1.5)  R.m.s. deviations   
Completeness (%) 98.2 (93.5)      Bond lengths (Å) 0.009  
Redundancy 3.4 (3.4)      Bond angles (°) 0.75  
Wilson B factor (Å2)** 139  Ramachandran (%)***   
       Favored 96  
  
     Allowed 4  
  
     Outliers 0  
* Values in parentheses are for highest-resolution shell. 
** Determined by BUSTER 
*** Determined by MolProbity. 
 
The model includes 39 out of 48 DNA bases present in the crystallization setup: bases 
5–23 of the top TATA box strand and 2–21 of the bottom strand) as well as 89% of the 
protein residues; TBP 19–196, Mot1 1–97, 143–411, 415–484, 487–503, 510–778, NC2α 15–
59 and 69–89, as well as NC2β 12–23, 29–101 and 110–137. The quality of the model can be 
additionally assessed by a fact, that a short 310 helix located on the C-terminus of NC2α was 
observed, although it was not present in the initial model used during molecular replacement. 
This part of the NC2α polypeptide chain was omitted from the construct used for the 
crystallization of the human TBP–DNA–NC2 complex. This C-terminal helix is, however, an 
integral part of the fold present in crystal structures of other histone fold domain-containing 
proteins (e.g. NF-Y heterotrimeric transcription factor [109]). In the case of the E. cuniculi 
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NC2 ortholog, the presence of this region was responsible the NC2α–NC2β complex 
integrity, since NC2α∆79-95 could not have been co-purified with NC2β (data not shown). 
 
 
4.2.2 Overview of the structure 
 
In the crystal structure, show in Figure 13, one copy of each Mot1NTD, TBP, NC2α, NC2β, 
and 24 bp DNA are found in the asymmetric unit and form an assembly of approximate 
dimensions of 100 Å x 100 Å x 95 Å. TBP slightly unwinds and sharply bends the TATA box 
DNA to form a unique saddle-shaped structure. Mot1 and NC2 seem to complement each 
other and form a “clamp” around promoter-bound TBP. The character of this interaction 
clearly explains NC2-dependent stabilization of the complex observed in EMSA and gel 
filtration and that Mot1 and NC2 do not interact in the absence of TBP and DNA. NC2 locks 
TBP on the promoter between its N-terminal histone fold domain (NC2HF), which is bound to 
the underside of the promoter DNA, and the convex site-bound C-terminal helix H5 of 
NC2β. The overall organization of the TBP–NC2–DNA complex in the Mot1NTD–TBP–
NC2–DNA crystal structure is highly similar to the human TBP–NC2–DNA complex [107]. 
Similarly, Mot1NTD engages TBP mostly from the TBP's convex and “upstream” side, which 
is highly comparable for both Mot1NTD–TBP and Mot1NTD–TBP–NC2–DNA crystal 
structures. 
Importantly, there is no interpretable electron density observed for the Mot1 latch 
region (residues 98–142), what indicates that this part of the polypeptide is disordered when 
Mot1 is bound to the TBP–DNA–NC2 substrate. This could occur because the Mot1NTD does 
not possess a proper binding site for the latch or perhaps the latch is intrinsically disordered 
and undergoes a disorder-to-order transition only upon TBP binding. Alternatively, the 
association of the latch could be negatively affected by the crystal packing. 
 
Mot1NTD and NC2 directly interact on the promoter-bound TBP 
Although the contacts of Mot1NTD and NC2 within the complex are mainly TBP- and/or 
DNA-mediated, these two regulators interact directly on promoter-bound TBP molecule. 
Direct interaction of Mot1NTD and NC2 leads to many small conformational alterations, 
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Figure 13. Crystal structure of the E. cuniculi Mot1NTD–TBP–DNA–NC2 complex. 
Front and side view of the structure and its secondary structure features. TBP is shown in blue. The HEAT 
repeats of Mot1NTD are annotated as HR and shown in yellow. N- and C-terminal ends of Mot1NTD are labeled N 
and C, respectively. The non-HEAT repeat regions and part of the latch region of Mot1NTD are shown in orange 
and magenta, respectively. The subunits of NC2 heterodimer with their key secondary structure elements are 
shown in light green (NC2α) and dark green (NC2β). DNA is depicted in gray. The upstream (U) and 
downstream (D) side of the promoter are marked. 
 
which will be discussed further in more detail. 
First, the “anchor” helix H5 of NC2β is bound to the upper side of the TBP’s convex 
side and forms direct contacts to the insertion domain of Mot1NTD, the only non-HEAT repeat 
stretch in the N-terminal part of Mot1. As a consequence of this interaction, the interface 
between Mot1NTD and TBP in the “substrate” state extends beyond HR 4 to 6 (as described 
for the “product” Mot1NTD–TBP complex [47]) towards the C-terminus of Mot1NTD and 
additionally engages HR7 to 10 and the insertion domain (Figure 14). Altogether, the 
interaction interface between Mot1NTD and TBP’s convex site increases from ~900 Å2 to over 
1500 Å2, as calculated using PISA server [136]. This interaction results in a substantial 
compaction of the α-helical HEAT repeat array. 
 
Mot1NTD binding affects the conformation of TBP, NC2, and DNA 
The analysis of the root mean square deviation (r.m.s.d.) between different TBP crystal 
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Figure 14. The interface between Mot1NTD and TBP in the presence of NC2 and DNA.  
Mot1NTD and TBP from the Mot1NTD-TBP structure, helix H5 of NC2β and TBP from the TBP-DNA-NC2 
structure as well as all three components from the Mot1NTD–TBP–NC2–DNA crystal structure are here 
superimposed via TBP (represented by a blue surface). The elements from the Mot1NTD–TBP–NC2–DNA 
crystal structure are color-coded as described in Figure 13, while the same elements from other structures are 
shown in light brown. This superimposition shows that Mot1 binding does not affect the position of H5 on TBP. 
However, the HEAT repeat array of Mot1 undergoes reorganization in the presence of its substrate by shifting 
towards helix H5. The residues localized on the surface of the interaction sites are annotated.  
 
structures shows that in the Mot1NTD–TBP–DNA–NC2 complex structure TBP is mostly 
similar to its “product”, Mot1-bound, state (r.m.s.d. of 0.69–0.87 Å) rather than to 
DNA-bound TBP (r.m.s.d. of 0.96) or free TBP (r.m.s.d. of 1.23 Å), superimposed in Figure 
15A. This suggests that Mot1 binding might potentially have a destabilizing effect on the 
TBP–DNA interaction. Consequently, the ~90° kink in the TATA box region appears to be 
less distorted than reported for numerous TBP–DNA complex structures, including the TBP–
DNA–NC2 complex (Figure 15B–C). This change results in the altered trajectory of the 
upstream DNA, bringing it closer to the N- and C-terminus of Mot1NTD (Figure 15C). This is 
of potential interest since this DNA region has been shown to be directly occupied by 
Mot1CTD [8], [9], [47], [59], [70]. Additionally, the first two HEAT repeats of Mot1 form a 
highly conserved and positively charged patch that is close to the upstream DNA and, in the 
context of full-length Mot1, could potentially contribute to a change in DNA trajectory 
induced by Mot1 binding.  
Despite the changes in the DNA conformation, the interaction between the NC2HF and 
upstream DNA closely resembles the interaction between the histones H2A/H2B and DNA 
within the nucleosome [108] and, consequently, in the TBP–DNA–NC2 crystal structure. A 
detailed analysis of the NC2HF–DNA interaction site mediated by helix H1 of NC2α and 
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Figure 15. Changes in the TBP, NC2 and DNA conformation induced by Mot1NTD binding. 
(A) Comparison of the TBP conformation in E. cuniculi TBP dimer (coral [47]), E. cuniculi Mot1NTD–TBP 
(cyan, [47]), H. sapiens TBP–DNA–NC2 (brown, [107]) and E. cuniculi Mot1NTD–TBP–DNA–NC2 (dark blue) 
crystal structures superposed via TBP’s helix H2. (B) and (D) Helix H4 of NC2β, which joins the NC2HF with 
helix H5, is partially unfolded and additionally loses its interaction with downstream DNA and may directly 
contact TBP’s N-terminal stirrup. Unfortunately, no electron density is visible for the side chains in this region. 
(C) Mot1NTD binding induces NC2HF and the upstream DNA (U) to shift toward the N-terminus of Mot1NTD. On 
panels (B), (C) and (D) the Mot1NTD–TBP–DNA–NC2 crystal structure is color-coded as in Figure 13 and 
superimposed with the TBP–DNA–NC2 structure (shown in light brown) via TBP. 
 
helix H1 of NC2β is not possible, since the side chains of this protein region are not visible in 
the electron density. However, general inspection supports the conclusion that the same 
interactions between positively charged side chains of H1 and H1 with DNA are preserved. 
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The results of altered upstream DNA trajectory as well as the fact that NC2HF–DNA 
interactions are maintained results in the situation, in which NC2HF is rotated and shifted 
towards Mot1 with respect to TBP in comparison to the conformation observed in the 
“substrate” TBP–DNA–NC2 complex. This additionally result in significant straightening of 
H4 of NC2β, which joins NC2HF bound to the underside of TBP–DNA and helix H5 bound to 
the TBP. Helix H4 of NC2β is stretched and adopts a partially unfolded conformation 
(Figure 15B,D). Moreover, the interaction between H4 and the major groove of the 
downstream DNA region is lost (Figure 15D). Instead, H4 potentially has a direct contact to 
TBP’s C-terminal stirrup, although this interaction is not well defined due to the poor side 
chain electron density. 
Very importantly for the discussion of the potential biological relevance of the 
observed changes, the upstream end of DNA is partially disordered and involved in the 
formation of crystal lattice contacts (Figure 25). The downstream DNA side clashes against 
the HEAT repeats belonging to the other complex. It has to be noted that the upstream DNA 
is directly involved in the formation of DNA–DNA contacts with other upstream DNA region 
of the molecule in the same unit cell (twofold symmetry). Therefore, the changes in the DNA 
trajectory reported here could be less or more prominent in the solution. 
 
 
 
4.3 EM and CX-MS analyses of the Mot1–TBP–DNA–NC2 complex 
 
The crystal structure of the E. cuniculi Mot1NTD–TBP–DNA–NC2 complex revealed that a 
direct interaction between the HEAT repeat domain of Mot1 and NC2 occur. Remarkably, the 
analysis also suggested that upon Mot1 binding the conformation of TBP and the upstream 
DNA in the TBP–DNA–NC2 substrate is affected. Therefore, additional analysis of the 
complex in the context of the full-length Mot1 was necessary to further investigate the 
protein and DNA rearrangements in the presence of Mot1CTD and to probe potential 
nucleotide-dependent differences. In order to allow this, electron microscopy (EM) and 
protein–protein crosslinking coupled to mass spectrometry (CX-MS) techniques were 
applied. 
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 The 5´ end flanking the TATA box promoter sequence was shown to be directly 
occupied by the Mot1CTD and to have a positive impact on the Mot1–TBP–DNA complex 
stability [8], [9], [47], [59], [70], [87]. Moreover, the upstream DNA region is required for 
the ATP-mediated dissociation of the Mot1–TBP–DNA complex in vitro [8], [70], [88]. 
Therefore, to stabilize Mot1CTD for the EM and CX-MS analyses, the Mot1–TBP–DNA–NC2 
complex samples were formed on long TATA box-containing DNA substrates with at least 26 
bp upstream from the TATA box. Additionally, FRET experiments showed that the 
conformation of Swi2/Snf2 domain depends on its nucleotide state [138]. Although the 
affinity of yeast Mot1CTD to DNA seems to be the highest in its nucleotide-free state [88], 
under these conditions SsoRad54-like Swi2/Snf2 protein was shown to freely switch between 
open and closed conformation in solution [138]. Such conformational heterogeneity would be 
highly undesirable for structural analysis. However, in agreement with structural analysis of 
other SF2 helicases, S. sulpholobus Rad54-like in the presence of ATP-mimicking analogues, 
was shown to adopt closed conformation in solution [138]. Importantly for this study, the 
addition of nonhydrolyzable ATP analogs does not lead to Mot1–TBP–DNA complex 
disruption [8], [45], [87], [88] and in some cases was even reported to stabilize the ternary 
complexes when compared to the ones formed in the absence of any nucleotide [45]. Thus, in 
order to ensure a uniform and rigid conformation of Mot1CTD, different nucleotides or 
derivatives were added to the complex samples after assembling and purifying the complexes 
in gel filtration: ABF, AGS, and ADP to lock Mot1CTD in ATP- or ADP-bound states, 
respectively [139]. 
 
 
4.3.1 Chemical site-specific protein–protein crosslinking 
 
The principle of CX-MS technique is based on the ability of so-called crosslinking 
compounds to specifically link two targets via their two distal functional groups. The 
maximal theoretical distance between the potential targets is restricted by the length of the 
carbon linker joining the adjacent reactive ends of the crosslinker. The molecule used in this 
study, di-sulfo-succinimidyl-glutarate (DSSG), is a noncleavable crosslinker of a total length 
of 11.4 Å that contains an amine-reactive N-hydroxysuccinimide ester at both ends of an 
RESULTS 
46 
eight-carbon spacer arm. The ester groups react exclusively with primary amines at a certain 
pH (7–9), namely ε-amino groups of lysines and N-termini of polypeptide chains. Light and 
heavy forms of this reagent contain six deuterium or six hydrogen atoms, respectively. Such 
isotopic coding enables the detection of the crosslinked peptides in the mass spectra.  
 In the first step, different crosslinking agent amounts were added to the gel filtered 
complex samples, according to the molar excess of the reagent over lysine residues (here, 
from 0.1 to 2.0). The calculations were based on an estimation that 1 µg of protein contains 
0.5 nmol of lysine residues, which reflects average occurrence of this amino acid in proteins. 
The crosslinked species were subsequently analyzed by SDS-PAGE and silver staining 
(Figure 16A). Initial testing enabled identification of the most optimal crosslinking ratio 
under tested conditions (30°C, 35 min). Excessive crosslinking may be too aggressive for the 
protein surface and lead to unspecific crosslinks or even aggregation. On the contrary, too 
low amounts of the crosslinking agent result in low crosslinking efficiency and only few 
crosslinks are detected.  
In the scaled-up experiments (~55 µg each), 133, 129 and 97 crosslinks within the 
ABF-, AGS- and ADP-supplied Mot1–TBP–DNA–NC2 complexes originating from 116, 109  
 
Table 2. Localization of the crosslinks identified in Mot1–TBP–DNA–NC2 complex.  
The first numbers refer to the total number of crosslinks, including crosslinked sites which were detected more 
than once (i.e. from miss-cleaved peptides). Numbers in brackets refer to nonredundant linkages only.  
 
Crystal 
structure 
Within Mot1CTD Latch-
crystal 
structure 
Latch- 
Mot1CTD 
Crystal 
structure- 
Mot1CTD 
Tot. Decoy4 
Intralobe1 Interlobe2 
         
ABF 46 (42) 
21 
(17) 
15 
(12) 
8 
(8) 
5 
(5) 
37 (31) 
+ 1 (1)3 
133 
(116) 2 
         
AGS 51 (44) 
17 
(14) 
10 
(9) 
11 
(11) 
3 
(3) 
37 
(28) 
129 
(109) 1 
         
ADP 40 (36) 
14 
(11) 
7 
(7) 
11 
(10) 
4 
(3) 
21 
(15) 
97 
(82) 2 
 
1
 Within RecA1 or RecA2 subdomain 
2
 Between RecA1 and RecA2 lobe 
3 Between Mot1CTD and the linker joining N- and C-terminal domains (could not be mapped) 
4 Detected from reverse database, estimating false-discovery rate 
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Figure 16. Chemical protein-protein crosslinking.  
(A) Titration of the crosslinker (DSSG) to the Mot1–TBP–DNA–NC2 complex samples supplied with ADP, 
AGS or ABF visualized by SDS-PAGE and silver staining. Numbers correspond to the molar excess of the 
crosslinker over lysines. The samples analyzed in this study were crosslinked at 1:1 lysine:DSSG molar ratio 
and prepared for the further mass spectrometry analysis (described in [89]). (B) Distribution of theoretical 
linkages within the Mot1NTD–TBP–NC2 module (right, n=5568) compared with the crosslinks detected in 
crosslinking experiments performed on Mot1–TBP–DNA–NC2 complex in the presence of ABF, AGS and ADP 
(n= 42, 44, 36, respectively). Only the nonredundant crosslinks were analyzed. The colored rectangles include 
distances within the first to the third quartile with the median value indicated as line. The whiskers represent 
one standard deviation above and below the mean (open square). Extreme values are represented by crosses. 
Raw data points were included for the experimentally determined crosslinks and were omitted for theoretical 
crosslinks due to the high n number. (C) General topology of the Mot1–TBP–DNA–NC2 complex in the 
presence of AGS derived from the CX-MS data. TBP (blue), Mot1NTD (yellow, pink and orange), Mot1CTD 
(purple), NC2α (light green), NC2β (dark green) are represented by blocks. Each polypeptide is divided into ten 
amino acid segments. The black solid lines represent the identified nonredundant crosslinks. For simplicity, 
crosslinks of the latch region were omitted. Line thickness is proportional to the number of crosslinks detected 
between the segments (redundant events). The dashed line between Mot1NTD and Mot1CTD segment represents 
the eight-amino acid linker joining these domains. 
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and 82 nonredundant linkage sites were detected. Table 2 summarizes the number and the 
localization of all of the detected crosslinks. The false discovery rate (for all data sets below 
2%) was calculated based on the total number of the detected crosslinks and the number of 
“decoy” crosslinks. Decoy crosslinks originate from the peptides included in a so-called 
“reverse” database, which consists of sequences of protein of interest but with amino acid 
sequences reordered from C- to the N-terminal direction. Most of the crosslinks from each 
data set could be placed within the Mot1NTD–TBP–DNA–NC2 crystal structure or within the 
Mot1CTD segment. The crosslinks that were detected between the latch residues Lys115 or 
Lys138 and other components of the complex could not be mapped, since the latch in the 
crystal structure is disordered. The rest of the crosslinks linked Mot1CTD and other parts of 
the complex. For example, in all data sets numerous crosslinks between Mot1CTD and NC2HF 
were found, mainly between the helix Hc and loop L2 of NC2α (joning Hc with H3) and the 
RecA2 subdomain of Mot1CTD. The crosslinks that could be mapped on the Mot1NTD–TBP–
DNA–NC2 crystal structure were compared with distribution of theoretical crosslinks 
originating from the linkages between all lysines within the complex. Figure 16B depicts the 
differences between the distribution of experimental and theoretical crosslinks. This analysis 
shows that the detected linkages have shorter distances (with median and mean values below 
30 Å) that it would be expected for false positives or if the crosslinks were resulting from 
random unspecific events (median and mean values ~50 Å). Schematic representation of the 
crosslinks obtained in the experiment performed on the Mot1–TBP–DNA–NC2 complex in 
the presence of AGS is shown in Figure 16C. 
 
Conformation of Mot1CTD is dictated by its nucleotide state 
The Swi2/Snf2 ATPase fold comprises two RecA-like subdomains which were shown to 
adopt a variety of different relative orientations in solution, even in the presence of DNA 
[138]. As has been shown for Mot1, the conversion between different states is necessary for 
the ATPase activity [59]. ATP binding site is located at the interface of the two subdomains 
and—according both to structural [79] and biochemical [138] characterization of other SF2 
enzymes—has been shown to stabilize the catalytically active, “closed” state. Importantly, as 
indicated by FRET analysis, the Swi2/Snf2 ATPase domain persists in the closed state not  
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Figure 17. Statistical analysis of the crosslinks between the RecA-like subdomains of Mot1CTD. 
(A) Cartoon representation of the changes in the relative orientation of the RecA-like subdomains occurring 
during the ATP hydrolysis cycle. RecA1A and RecA2A folds of the ATPase core are represented by pink and 
purple shapes, respectively. Swi2/Snf2 family-specific insertions (1B and 2B) are depicted by blue shapes. The 
ATP binding pocket formed on the interaction surface between subdomains 1A and 2A is shown in gray. Only 
the closed conformation supports the ATP hydrolysis [79]. The linker and brace regions were omitted. The 
dotted red lines, which represent a theoretical crosslink between two sites, show that the relative orientation of 
RecA-like lobes will have a drastic effect on the crosslinking efficiency between particular sites. (B)–(D) 
Distance distribution of the nonredundant crosslinks detected within Mot1CTD domain in the presence of 
different nucleotides. Numbers in the brackets refer to the number of crosslinks used in this analysis. The means 
were significantly heterogeneous in one-way repeated-measures ANOVA test for all three data sets (p<0.05) 
with the conformation as the factor. Box plot description is same as described in Figure 16. 
 
only when bound to ATP, but also in the presence of ATP-mimicking analogs [138]. On the 
contrary, in the ADP-bound either a semi-open conformation or dynamic equilibrium 
between open and closed state occur [138].  
In order to assess the Mot1CTD conformation in the presence of different nucleotides, 
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all crosslinks detected in the ATPase region (both inter- and intra-subdomain) were mapped 
on the three Mot1CTD homology models. Of note is that only nonredundant crosslinks were 
used in this analysis. All redundant crosslinks—additional 7, 4 and 3 for ABF, AGS and ADP 
data sets, respectively (see Table 2) —were omitted, since including redundant events would 
be relevant only if the probability to detect each single crosslink would be the same. The 
models used in this analysis were generated using ESyPred3D Web Server [140] and based 
on the crystal structures of D. rerio Rad54 [77], S. cerevisiae Chd1 [54] and S. solfataricus 
Rad54-like protein [76]. Importantly for the analysis, each of the listed Swi2/Snf2 domains 
was trapped in a different conformation: “closed”, “semi-closed” and “open”, respectively 
(see Figure 3). As expected, the analysis of the crosslinks detected in different nucleotide 
state suggested that Mot1CTD in the presence of ABF and AGS (ATP-mimicking analogs) 
adopts predominantly “closed” conformation, supporting properly formed nucleotide binding 
cleft (Figure 17B–C). In contrast, the distance distribution of the crosslinks in the presence 
of ADP suggests that Mot1CTD has mixed conformations when bound to this nucleotide 
(Figure 17D). 
 
Position of Mot1CTD within the complex can be determined via CX-MS analysis 
The analysis of Mot1CTD conformation in the presence of ADP or ATP-mimicking analogs 
fully supported previous hypotheses and observations described for other Swi2/Snf2 ATPases 
[138]. Given that crosslinking data appeared as a potent source of valuable information, 
another test was carried out in order to assess the localization of Mot1CTD within the E. 
cuniculi Mot1–TBP–DNA–NC2 complex, based exclusively on CX-MS data. The schematic 
cartoon presenting the workflow of this approach is depicted in Figure 18A). First step 
required high-throughput generation of a large number of potential relative orientations of 
Mot1CTD and the Mot1NTD–TBP–NC2 submodule. For this purpose, EOM (ensemble 
optimization method) package, which is used in one of the initial stages of small angle X-ray 
scattering data processing (SAXS) was used [141]. For flexible biological systems, 
interpretation of the scattering data is often not feasible because of significant conformational 
heterogeneity. EOM package allows quantitative analysis, which allows for a co-existence of 
multiple conformers in solution. First step of data analysis exploited RANCH, which 
according to given restrictions like symmetry operators or linker length, generates a pool of  
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Figure 18. Analysis of the Mot1CTD position and orientation via analysis of the crosslinking data. 
Workflow of the high-throughput CX-MS-based approach. The Mot1NTD–TBP–DNA–NC2 crystal structure and 
the Mot1CTD homology model served as templates for the generation and scoring of 20,000 of different 
nonredundant Mot1CTD placements (see text). (B) Distribution of the violation scores among all of the models 
for both of the analyzed data sets. Top 12 models with lowest violation scores (19 and below for ABF and 17 
and below for AGS, additionally shaded) are shown in Figure 19.  
 
random conformations of the given domains to construct the whole macromolecule. Models 
yielding sterical clashes are rejected such that the pool contains only physically relevant 
conformations. RANCH software allows generating the models in three different modes, 
depending on the Cα angle distribution used for modeling of the missing regions: random (Cα 
angle distribution consistent with chemically denatured proteins, therefore producing more 
extended models), native (consistent with disordered proteins) and compact (consistent with 
disordered proteins but forcing the reconstructed linkers to be rather compact). In accordance 
with the initial analysis of CX-MS data, the homology model of Mot1CTD domain used in this 
test was based on the eukaryotic Rad54 structure in closed conformation. According to the 
RANCH protocol, the position of Mot1CTD was restrained consistent with the presence of 
eight amino-acid linker between Mot1NTD and the Mot1CTD model (Mot1 residues 779–786). 
This short linker was not included in the construct used for the determination of the Mot1NTD 
crystal structures. The models presented here were generated in compact mode, however no 
significant impact of the used mode of the model generation and further data interpretation 
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was observed.  
Next, all the nonredundant crosslinked pairs from the ADP, ABF, and AGS data sets 
detected between Mot1CTD and the Mot1NTD–TBP–NC2 submodule were mapped on the 
computed models. Further, the distances of each detected crosslink for all of the generated 
theoretical models were written out and scored according to a recently published protocol 
([142] for the detailes, please see section 6.7.4). The scoring protocol was based on the 
violation of an arbitrarily set cutoff distance, accounting for the length of the used crosslinker 
and linked side chains (here, lysines). For a particular model, to each crosslink a value was 
assigned: 0 if the distance between the Cα of the crosslinked residues was equal or below the 
given cutoff, or 1 in case the distance was longer. In this analysis, different cutoff values 
were tested: 30, 35 and 40 Å. The analysis performed applying a 40 Å cutoff did not allow to 
select a sharp solution, suggesting that the cutoff value was too high. However, applying 30 
or 35 Å cutoff for the AGS and ABF data sets (with 28 and 31 crosslinks, respectively) sharp 
top solutions were obtained (Figure 18B). There was no substantial difference between the 
solutions obtained for 30 and 35 Å cutoffs. Remarkably, exactly the same models appeared as 
the global minimum (lowest number of violating crosslinks) for both of the analyzed data 
sets (shown in Figure 19B).  
 
Figure 19. Mot1CTD placement derived from the CX-MS data. 
Superimposition of 12 randomly chosen (A) and 12 best-scoring models (B), shown in different colors and 
superimposed via the Mot1NTD–TBP–NC2 module (gray surface). (C) Comparison of the relative orientations of 
best-scoring Mot1CTDs represented via rainbow-coloring from the N- (blue) to the C-terminus (red) of the 
Mot1CTD model. This interpretation of the crosslinking data shows not only that this method allowed to narrow 
down the probed space suggesting an approximate position of Mot1CTD within the Mot1–TBP–DNA–NC2 
complex, but also that it consequently points at a defined orientation. 
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The number of the nonredundant crosslinks detected between Mot1CTD and the rest of 
the complex in the ADP data set (15) was too small to select a subset of models representing 
the global minimum of the scoring function, regardless of the cutoff value used. For example, 
for the 30 Å cutoff there was 74 best-scoring solutions for the ADP data set (not shown) and 
only one best solutions for each ABF and AGS data sets (Figure 18B). Moreover, the 
solutions for the ADP data set were not related, further suggesting that the number of the 
crosslinks detected in this particular sample was not high enough. 
 
 
4.3.2 Electron microscopy negative stain 
 
In parallel to the CX-MS experiments, the Mot1–TBP–DNA–NC2 complex in the presence 
of different nucleotides was visualized by negative stain electron microscopy technique. In 
negative staining, the particles are fixed in a layer of heavy metal solution—in this case, 
uranyl acetate—which fixes protein structure on the millisecond timescale [143]. Using 
 
 
Figure 20. EM data. 
(A) Negative stain micrograph of the E. cuniculi Mot1–TBP–DNA–NC2–ABF complex. (B) Electron density 
map of reconstruction. The map was contoured at a volume of ~300,000 Å3 which corresponds to the theoretical 
volume of the atomic models. (C) 2D class averages (bottom) and the back-projections of the 3D model in the 
Euler angle directions assigned to the class averages (top). 
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computational tools, images of negatively stained specimens at different views are combined 
and used to produce three-dimensional reconstructions of the molecule. This, due to the size 
of the microcrystals formed by the staining solution, can be achieved to about 20 Å. The 
attempts to calculate EM reconstructions of the Mot1–TBP–DNA–NC2 complex in the 
presence of ADP or AGS were challenging and ineffective. However, the 22 Å negative stain 
reconstruction of the complex in the presence of ABF was successfully calculated from 8,192 
selected particles (Figure 20). The reconstruction, of overall approximate dimensions of 
115 Å x 115 Å x 100 Å, is in good agreement with the size of the partial complex observed in 
the crystals structure. Moreover, the characteristic C-like shape of Mot1NTD is pronounced 
(Figure 21). 
 
 
Figure 21. Results of the rigid-body fitting into the EM density. 
(A) The crystal structure of the Mot1NTD–TBP–DNA–NC2 complex (color-coded as in Figure 13) rigid-body 
docked into the negative stain density map of the Mot1–TBP–DNA–NC2–ABF complex (transparent, gray). 
(B) The map divided with the Segger tool (included in Chimera package [146]) into two segments: Mot1NTD–
TBP–NC2 module (transparent, gray) and Mot1CTD part (opaque, purple).  
 
 
Rigid-body fitting 
To combine the structural information from the crystal structure and the EM reconstruction, 
an unbiased rigid body fitting approach was used in order to unambiguously localize the 
Mot1NTD–TBP–NC2 submodule, with the DNA molecule omitted, in the EM density. The 
fitting was performed using colores tool [144], part of the Situs software package [145]  
 (available at http://situs.biomachina.org). The program performs an extensive 6-dimensional 
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contour matching of a down-filtered probe structure relative to the target EM density map. 
The fitting protocol resulted in a very convincing solution in which a centered additional 
density is visible. This additional density is situated upstream from the HEAT repeats of 
Mot1, directly next to the N- and, most importantly, the C-terminal end of the Mot1NTD 
construct (Figure 21). Thus, this prominent segment likely harbors the Swi2/Snf2 domain.  
 
 
4.3.3 Pseudo-atomic model of Mot1–TBP–DNA–NC2 complex 
 
The in-depth CX-MS and EM analyses resulted in an equivalent outcome and suggested the 
same localization of Mot1CTD relatively to the Mot1NTD–TBP–NC2 module, placing it on the 
upstream side of TBP, in a direct proximity to the C-terminus of Mot1NTD and NC2HF. Very 
convincingly, in such configuration the DNA fragment from the Mot1CTD component, which 
can be modeled based on the SsoRad54-DNA crystal structure superposed via RecA1 lobe, is 
a direct continuation of the upstream DNA from the Mot1NTD–TBP–DNA–NC2 crystal 
structure (Figure 22A). The anticipated trajectory of the “handle” DNA engaged by Mot1CTD 
with respect to Mot1NTD–TBP does not seem to be altered and primarily follows the usual 
path of upstream DNA flanking the TBP-bound TATA promoter DNA. Thus, this localization 
agrees with the placement established in previous structural and biochemical studies [8], [9], 
[47], [59], [70]. The discrepancies between the exact placement (Figure 22B) result from the 
fact that the complex shape is likely more compact than it is suggested by the models 
generated for the CX-MS analysis. However, rigid-body fit of the Mot1CTD model into its 
segment shows that the Mot1CTD segment could theoretically hold the ATPase domain 
(Figure 22C) if small adjustments of the polypeptide chains, especially in the HEAT repeat 
region were allowed. 
Although slight rearrangements within Mot1–TBP–DNA–NC2 complex at the TATA 
box cannot be excluded, the analysis also implies that Mot1CTD would contact not more than 
20 bp upstream from the TATA sequence (Figure 22D), which would be in agreement with 
the length requirement reported for the yeast Mot1, which ATPase domain was reported to 
contact around 17 bp upstream from the TATA box [47]. Furthermore, it seems plausible to 
reason that the non-TATA box-containing strand would be the one which Mot1CTD uses  
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Figure 22. Comparison of the Mot1–TBP–DNA–NC2 complex model obtained from the CX-MS data with 
the EM electron density map.  
(A) The model of the full Mot1–TBP–DNA–NC2 complex based on the CX-MS analysis. For clarity, one 
representative model was chosen. (B) Superimposition of the EM map segments, Mot1NTD–TBP–DNA–NC2 
crystal structure and one of the best-scoring CX-MS-based Mot1CTD model fits. The transparent purple segment 
corresponds to the Mot1CTD segment and the transparent gray one to the Mot1NTD–TBP–NC2 module (same as 
in Figure 21). RecA1-like and RecA2-like subdomains of the Swi2/Snf2 domain are pink and purple, 
respectively. B1 and B2 insertions are in blue. The position of the DNA fragment bound to Mot1CTD was 
modeled based on the SsoRad54-like–DNA crystal structure by superimposing them via RecA1 subdomain (C) 
Mot1CTD homology model from (A) and (B) rigid-body fitted into the Mot1CTD segment using Chimera “Fit to 
segments” tool [146]. (D) Relative positions of TATA box-bound TBP and the Mot1CTD bound to the upstream 
DNA. The top TATA box strand from the Mot1NTD–TBP–DNA–NC2 crystal structure is in red. The TATA box 
sequence was additionally highlighted in orange. The DNA strand, which forms main contacts within the 
SsoRad54-like protein-DNA structure (the 3’–5’ tracking strand, see Figure 3C) is also marked in red. Color 
coding of the Mot1NTD–TBP–DNA–NC2 structure shown in (B) and (D) is same as described in Figure 13. 
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primary for tracking (3’–5’ strand, compare Figure 22D and Figure 3). 
Interestingly, the analysis of the negative stain reconstruction suggests that the DNA 
substrate is partially visible, since clear density is present at the predicted DNA binding site 
(Figure 22B and C as well as Figure 20B, front view). Although local protein–DNA 
environment might distort stain adsorption, cases in which DNA could be well visualized by 
the negative stain method are reported, e.g. p53–DNA complex [147].  
 
 
 
4.4 Preliminary X-ray crystallographic analysis of the Mot1NTD–TBP–
NC2β complex 
 
4.4.1 Crystallization and structure determination 
 
Mot1 catalyzes the ATP-dependent displacement of protein substrates from DNA [8]. 
However, the experiments performed on the E. cuniculi proteins revealed that Mot1 can not 
only bind to TBP–DNA and TBP–DNA–NC2 complexes, but also can simultaneously form 
complexes with TBP and NC2β in the absence of DNA. Thus, in order to gain some 
structural insights into potential physiological function of such Mot1–TBP–NC2β 
assemblies, Mot1–TBP–NC2β and Mot1NTD–TBP–NC2β complex samples purified by gel 
filtration were subjected to crystallization experiments. In few of the tested conditions 
crystals of various morphologies were obtained. Initial poorly shaped crystals of the 
Mot1NTD–TBP–NC2β complex diffracted only maximally to 5 Å (Figure 23A,B) and were 
subsequently used as a source of nucleation seeds in streak seeding experiments. After 3–14 
days of incubation this approach led to well-shaped crystals diffracting maximally to 3.3 Å 
(Figure 23C). In some of the crystallization conditions the complex sample was not stable 
enough and only Mot1NTD–TBP crystals were obtained (Figure 23D). 
The data set from a crystal of the Mot1NTD–TBP–NC2β complex, which was used for 
the refinement, was collected at λ=0.9797 Å and 100 K. The complex crystallized in the 
space group P 1 21 1 (a=116.8 Å, b=150.1 Å, c=172.8 Å, α=90.0°, β=107.1°, γ=90.0°) with 
55% solvent content and four of each Mot1NTD, TBP, and NC2β chains in the asymmetric  
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Figure 23. Results of the crystallization of E. cuniculi Mot1NTD–TBP–NC2β complex. 
(A) Initial hits of the E. cuniculi Mot1NTD–TBP–NC2β complex crystals. Typical hedgehoge-like clusters of 
crystals were grown in 0.1 M sodium citrate pH 5–6, 0.2 M ammonium sulphate and PEG4000. (B) First hits of 
thin plate-like crystals grown in 0.1 M sodium citrate pH 5–6, 0.2 M sodium malonate and PEG4000. The 
crystals shown in (C) were obtained by streak seeding of the crystals presented in (B) and diffracted to 3.3 Å. 
(D) Crystal of Mot1NTD–TBP complex covered in crystalline precipitate growing in 0.1 M magnesium acetate, 
0.1 M sodium citrate 5.5 and 6% PEG4000. The crystal diffracted to 3.2 Å. 
 
unit (~4500 residues in total). The structure was solved by molecular replacement using the 
E. cuniculi Mot1NTD and TBP from the Mot1NTD–TBP complex crystal structure [47] as 
separate search models. Subsequently, parts of the NC2β chains were modeled. Subsequently, 
the model was refined at 3.3 Å resolution to initial Rwork/Rfree of 23.5%/26.9%. Data 
collection, processing and refinement statistics can be found in Table 3. 
 
 
4.4.2 Overview of the structure 
 
Mot1 has a tight grip on TBP 
In the Mot1NTD–TBP–DNA–NC2 crystal structure the interface between Mot1NTD and TBP 
extended from HR4 to HR10 and included the insertion domain (Figure 14). As shown in 
Figure 24, in the Mot1NTD–TBP–NC2β crystal structure this interaction interface is 
preserved and further increases to reach ~1800 Å2 (calculated by PISA server [136]). Thus, in 
the Mot1NTD–TBP–NC2β crystal structure the contact surface between Mot1NTD and the 
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convex site of TBP is two times larger than in the Mot1NTD–TBP complex. 
 
Table 3. Data collection and refinement statistics.  
Equations defining R-values are standard and hence not defined.  
 
Data collection    Refinement   
Space group P 1 21 1  Resolution (Å) 44.47–3.29 (3.33–3.39)  
Cell dimensions   Rwork/Rfree (%) 23.5/26.9(38.5/43.6)  
 
 
    a, b, c (Å) 116.8, 150.1, 172.8  No. atoms   
    α, ß, γ (°)  90.0, 107.1, 90.0      Protein 32525  
Resolution (Å) 44.5–3.3 (3.5–3.3)*  B-factors (Å2)   
No. reflections       Protein 110  
    All 273046 (35071)  R.m.s. deviations   
    Unique 83621 (12355)      Bond lengths (Å) 0.004  
R merge (%) 9.0 (78.1)      Bond angles (°) 1.020  
CC(1/2) 99.8 (58.5)  Ramachandran (%)**   
I/σI 11.15 (1.43)      Favored 96.0  
Completeness (%) 96.8 (89.2)      Allowed 3.2  
Redundancy 3.3 (2.8)      Outliers 0.8  
Wilson B factor (Å2)** 102     
* Values in parentheses are for highest-resolution shell. 
** Determined by MolProbity.  
 
In both of the crystal structures described in this thesis, Mot1NTD molecule via its C-
terminal ends packs against another Mot1NTD molecule in the same asymmetric unit 
(Mot1NTD–TBP–NC2β) or against a symmetry-related one (Mot1NTD–TBP–DNA–NC2). 
Remarkably, similar interaction is found also in the crystal structure of the Mot1NTD–TBP 
complex (all presented in Figure 25). Thus, it appears that Mot1NTD has a preference for 
particular crystal packing in which the C-terminal HEAT repeats self assemble to form a 
pseudocontinuous domain. Although driven by an analogous interaction, in order to 
accommodate the crystal lattice packing, the HEAT repeat domains adapt slightly different 
conformations undergoing “accordion-like” adjustments (Figure 25, right panels). The 
capability to rearrange was shown to be an important property of long α-helical solenoids 
[137]. Therefore, it is possible that the shape adaptation and conformational changes play a 
crucial role in the function of Mot1’s HEAT domain. For example, the position of helix H5 of 
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NC2β—which remains bound in the same manner in all of the analyzed structures (shown in 
Figure 14, Figure 24, and Figure 26)—would be well suited for the recognition of 
NC2-bound TBP or TBP–DNA complexes via Mot1NTD. Remarkably, the very C-terminal 
unstructured regulatory region of NC2β extending beyond the ordered parts of the 
polypeptide chain was shown to be responsible for the repressive role of NC2 in vitro and in 
vivo [106], [122]. It is, however, important to stress that loosening or strengthening of the 
interface area between Mot1NTD and TBP cannot be easily interpreted in the context of 
associated subunits, but is highly dependent on the organization of the crystal lattice contacts 
in particular crystal form. 
 
 
Figure 24. The interface between Mot1NTD and TBP in the presence of NC2β.  
Mot1NTD (light brown) and TBP (not shown) from the Mot1NTD–TBP structure as well as Mot1NTD, TBP, and H5 
of NC2β from the Mot1NTD–TBP–NC2β crystal structure (color-coded as in Figure 13) were superimposed via 
TBP (blue surface). The residues forming a hydrophobic cluster—localized at the interface of NC2β’s H5, 
TBP’s convex side and Mot1NTD’ insertion domain—are displayed on the right side. 
 
 
NC2β adopts an unusually extended conformation 
Although the interaction site between Mot1NTD and TBP’s convex surface remains largely 
unchanged, the latch region is 180° rotated about TBP’s twofold pseudosymmetric axis 
(Figure 26A). This unexpected feature can be explained by the fact that the latch does not 
form many specific contacts to TBP [47] and mimics DNA’s phosphate moiety, which also 
has internal pseudosymmetry. Of note is that the 180°-rotated binding mode is only possible 
because the latch binds TBP molecule from another complex as a result of “domain  
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Figure 25. Crystal contacts between two Mot1NTD molecules within the unit cell.  
Packing of two Mot1NTD molecules within the asymmetric unit of the Mot1NTD–TBP crystal structure (A) and 
within the asymmetric unit of the Mot1NTD–TBP–DNA–NC2 crystal structure (B). Panel (B) additionally shows 
that the upstream DNA ends probably form contacts in the crystal lattice. The 5’ end of the TATA strand (*) 
shown here in gray has four nucleotides missing and the 3’ end of the bottom strand (**) shown in black has 
three nucleotides missing. (C) Packing within the unit cell of the Mot1NTD–TBP–NC2β crystal structure. 
Dimerization of Mot1NTD molecules is mediated by two helices of NC2β inserted between the C-terminal HEAT 
repeats (darker pink and green). The black symbol in the middle of the left panel represents the twofold axis 
perpendicular to the plane of the screen. The axis on the right panel is represented by the dashed line. On panels 
(A) and (B) the twofold axis corresponds to the non-crystallographic axis, whereas on panel (C) it is the 
crystallographic axis. TBP and NC2α chains were omitted in all panels. Part of the NC2β chain is shown only in 
(C). 
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swapping” (Figure 25C, right side). Thus, the latch is unlikely to bind to TBP chain from the 
same complex in such manner, unless large conformational changes of the HEAT repeats 
would occur. Indeed, dimerization of Mot1NTD in the crystal lattice is supported by the 
detection of dimeric Mot1NTD–TBP–NC2β and Mot1–TBP–NC2β species in gel filtration. 
This implies that similar “dimeric” complexes could be also found in solution. However, it is 
not clear whether the dimerized form of the Mot1NTD–TBP–NC2β complex observed in the 
crystals structurally represents the multimeric species of Mot1–TBP–NC2β complex detected 
in gel filtration (see discussion). 
 
 
Figure 26. Unusual conformations of Mot1NTD latch and NC2β observed in the Mot1NTD–TBP–NC2β 
complex structure. 
(A) The latch (magenta) bound to TBP (blue) in the Mot1NTD–TBP–NC2β complex structure is 180° rotated 
about TBP’s twofold pseudosymmetric axis. The binding mode of the latch region observed in the Mot1NTD–
TBP crystal structure (approaching from the N-lobe’s side) is shown in light brown. Panel (B) shown unusually 
extended conformation of the NC2β chain (green) compared to the arrangement reported for the Mot1NTD–TBP–
DNA–NC2 crystal structure (light brown). Only helix H5 remains in the same position. Helix H4 is mostly 
unstructured or disordered and contacts TBP and the latch via shor helical regions (here referred to as H4A and 
H4B). Helix H3 belongs to the same or to the symmetry-related NC2β chain (symbolized by a question mark). 
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Apart from the change in latch binding, the NC2β chain, when compared to its 
conformation observed in the Mot1NTD–TBP–DNA–NC2 or TBP–DNA–NC2 crystal 
structures, adapts unusually extended conformation (Figure 26B). Helix H5 remains bound 
to TBP’s convex site, whereas mostly disordered helix H4 binds both to the latch and TBP 
via two short helical structures (here referred to as H4A and H4B). Moreover, helix H3—
typically participating in the formation of the histone fold—undergoes rotation and together 
with H4A binds to TBP’s C-terminal lobe (Figure 26B). Importantly, due to the relatively low 
resolution of the structure (3.3 Å) and the fact that NC2β residues 80–90 are unstructured, it 
is not clear to which complex each of the helices H3 belongs to (Figure 27A). The tracing of 
the N-terminal part of the NC2β chain (residues 1–65) is even more challenging. This part of 
the polypeptide chain is not visible apart from a two short symmetry-related α-helical regions 
inserted between the N- and C-terminal ends of Mot1NTD (Figure 25C, left panel and Figure 
27). Although these helices are up to 15 amino acids long, it is not possible to unambiguously 
determine the sequence register based on the electron density. However, these helices most 
probably correspond to H2 (and related H2´) of NC2β, core helices of the histone fold 
 
  
Figure 27. Tracing of the N-terminal residues of NC2β. 
(A) The NC2β chain cannot be entirely traced and the sequence register cannot be assigned for the residues 1–
65. (B) Only short ~15 amino acids long α-helical region (green) inserted between the C-terminal ends of 
Mot1NTD is visible. HR16 and C-terminal helix of Mot1NTD are shown in yellow and orange, respectively. The 
symmetry-related region of Mot1NTD was omitted, while both miscellaneous helices are shown. Panel (C) shows 
the 2Fo – Fc (blue mesh) and Fo – Fc (green mesh) electron density maps contoured at 1.5 and 3σ, respectively. 
Positive difference density is visible for some of the side chains. 
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domain (see e.g. Figure 4 or Figure 13). Like for its C-terminal part, the miscellaneous 
helices interact with neighboring molecules via very hydrophobic interaction, which likely 
compensate elongated conformation in the absence of the associated NC2α subunit of the 
NC2 heterodimer. However, the interaction between H2 and H2´ does not resemble the 
interaction within the histone fold. 
Of note is that in this configuration the cysteine residues of NC2β (C43 and C58) 
would be in close proximity to each other. In particular, the distance of symmetry-related 
C43 residues, which are localized on helices H2 and H2´, would theoretically allow the 
formation of disulfide bonds. The formation of disulfide bonds cannot be excluded, since 
reactive thiol groups are exposed and subjected to nonreducing conditions during 
crystallization process.  
 
 
 
4.5 Activity measurements 
 
4.5.1. Electrophoretic mobility shift assays 
 
Mot1 dissociates TBP–DNA–NC2 complexes in presence of ATP and the latch 
Mot1-catalyzed ATP-dependent disruption of TBP–DNA–NC2 complexes was already 
demonstrated for the recombinantly expressed yeast proteins in EMSA experiments [48] as 
well as for Mot1–TBP–DNA–NC2 complexes isolated from chromatin extracts [97]. Thus, 
EMSA experiments in the presence of ATP were performed for the E. cuniculi proteins in 
order to test if Mot1 is able to disrupt both TBP–DNA and more stable TBP–DNA–NC2 
complexes in the presence or the absence of the latch.  
As expected, Mot1 was able to efficiently dissociate TBP–DNA complexes when ATP 
was added (Figure 28A, lanes 3 and 4). The same effect was observed in the presence of 
NC2 (lanes 8 and 9). Interestingly, the presence of the latch was required to dissociate the 
Mot1–TBP–DNA–NC2 complexes, while Mot1 was able to disrupt the TBP–DNA 
complexes to some extent in the absence of the latch after ATP was added (Figure 28A, lanes 
5 and 6 vs 10 and 11 and [47]). Additionally, the addition of NC2 prevented ATP-independent 
premature dissociation of TBP–DNA complexes observed in the presence of Mot1NTD 
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(Figure 28B). 
 
Figure 28. Electrophoretic mobility shift assays. 
(A) Upon ATP addition, Mot1 dissociates TBP from DNA (lanes 3 and 4) as well as the TBP–DNA–NC2 
complex (lanes 8, 9). Mot1∆latch is less efficient in TBP removal (lanes 5, 6) and is not able to dissociate the 
TBP–DNA–NC2 complex (lanes 10, 11). (B) Addition of NC2 prevents the Mot1NTD from displacing TBP from 
DNA (lane 3 vs 6). (C) EMSA performed using DNA substrates, which had one of the 5’ ends labeled with 
fluorescein. Second 5’ end was labeled with digoxygenin and blocked by the addition of anti-digoxygenin 
antibody. (D) Cartoon representing the label placement of the substrates used in lanes 1-6 (top) and 7-12 
(bottom). Fluorescein, digoxygenin, and anti-digoxygenin antibody are represented by star, filled circle and a Y-
like shape, respectively. 
 
Interestingly, the quantification of EMSA experiments showed no clear differences 
between the affinities of Mot1 to TBP–DNA–NC2, NC2 to Mot1–TBP–DNA or NC2 to 
TBP–DNA (not shown). Each of the affinities was in low nM range and was thus similar to 
the affinity of yeast Mot1 to TBP–DNA complex [43, 46], which could not be reliably 
measured for the E. cuniculi proteins. Moreover, the presence of NC2 did not significantly 
affect the ATPase activity of Mot1, which required only TBP or TBP–DNA for the full 
stimulation [47]. 
Taken together, both TBP–DNA and TBP–DNA–NC2 complexes are bona fide 
substrates for Mot1-catalyzed ATP-dependent activity in vitro. NC2 blocks the premature 
action of the latch but neither increases Mot1’s affinity for the substrate nor affects its 
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ATPase activity. Moreover, the analysis of selected NC2 mutants was not possible, since they 
all showed WT behavior (data not shown).  
 
Mot1 dissociates TBP–NC2 from DNA substrates with obstructed ends 
Although Swi2/Snf2 ATPase motors couple ATP hydrolysis to dsDNA translocation [71]–
[73], the release of TBP from DNA by Mot1 does not appear to involve highly processive 
ATP-dependent DNA tracking [85]. However, Mot1 was shown to induce changes in the 
upstream DNA conformation within the TBP–DNA complexes, which suggested that Mot1 
straightens DNA [88]. Similarly to Mot1, lateral mobility of TBP–NC2 complexes on 
different DNA substrates was observed in single particle FRET experiments [114]. In 
addition, the same study showed that these mobile TBP–NC2 complexes were “trapped” on 
the DNA substrates and were not able to dissociate on their own, showing remarkable 
stability over long incubation times. Nevertheless, E. cuniculi Mot1 readily dissociated TBP 
from promoter DNA in the presence of NC2. Remarkably, in the Mot1NTD–TBP–DNA–NC2 
crystal structure, Mot1 and NC2 form a “clamp” on the promoter DNA-bound TBP. This 
kind of configuration would be well suited for ATP-dependent translocation along DNA 
track, since the structural analysis indeed indicates changes in the DNA trajectory that are 
consistent with increased lateral mobility of the Mot1–TBP–DNA–NC2 complex.  
Thus, in the light of the data presented in this study, two possible models of the 
ATP-dependent Mot1’s action could be proposed, both of them are represented schematically 
in Figure 29. First of the possibilities applies ATP-dependent translocation along DNA 
phosphate backbone (A). In an alternative scenario (B), the TBP–DNA–NC2 complex would 
be disrupted by locally occurring Mot1-induced conformational changes that do not require 
substantial translocation. To distinguish between these two possibilities, electrophoretic 
mobility shift assays, using digoxygenin labeled DNA and anti-digoxygenin antibodies. As 
shown in Figure 28C, although TBP–DNA complexes were not disrupted with 100% 
efficiency, the presence of the antibody in principle did not have any significant impact on 
the action catalyzed by Mot1, either in the presence or absence of NC2. Thus, these activity 
assays suggest that Mot1 does not motor the protein substrate along DNA over long 
distances, supporting similar results obtained with yeast proteins in an analogous set up [85]. 
Instead, Mot1 is more likely to locally disrupt the protein–DNA interaction. It is, however, 
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possible that the Mot1-catalyzed reaction includes very short-range tracking of TBP–NC2 
“clamps” (few base pairs), which cannot be distinguished from a local disruption on DNA 
substrates used in this study.  
 
 
Figure 29. Possible models of Mot1’s action on TBP–DNA–NC2 substrates. 
(A) Mot1 slides TBP–NC2 complexes along DNA away from the promoter or (B) Mot1 locally disrupts TBP–
NC2 complexes in a reaction, which does not require DNA tracking. 
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5. DISCUSSION 
 
 
5.1 TBP–DNA–NC2 complex is a bona fide substrate for Mot1 
 
Mot1 is an essential gene regulator that, as has been shown in numerous in vitro as well as 
genome-wide in vivo studies, together with NC2 regulates TBP’s genomic distribution [18], 
[20], [26], [97]. The question whether Mot1 and NC2 function through different but partially 
redundant mechanisms or whether they cooperate utilizing an unknown mechanistic 
relationship was not entirely clear. NC2 acts via preventing the interaction of TFIIA and 
TFIIB with TBP–DNA complexes, thereby blocking the PIC formation [94]–[96], [100], 
[102], [104], [113]. Interestingly, in vitro FRET experiments showed the extremely low off-
rate of TBP–NC2 complexes from promoters suggesting a requirement for a factor that 
modulates promoter accessibility [114]. Subsequently, NC2 was shown to be retained on 
DNA in vivo in the absence of functional Mot1 [19], [97], [118]. Moreover, intact Mot1–
TBP–DNA–NC2 complexes were isolated from yeast chromatin extracts and could be 
formed in vitro using recombinantly purified components [97], [48]. Finally, both 
endogenous and recombinant complexes were efficiently disrupted in the presence of ATP 
[97], [48]. In agreement with these results, the gel filtration and EMSA analyses performed 
on the E. cuniculi proteins showed that, next to TBP–DNA, also TBP–DNA–NC2 complex is 
a bona fide substrate for Mot1’s ATP-dependent activity. Additionally, in the absence of 
NC2α, TBP–DNA–NC2β and Mot1–TBP–DNA–NC2β complexes could not be formed, 
showing that both NC2 subunits are required for the formation of the DNA-containing 
complexes. Thus, current body of data suggests that the co-association of Mot1 and NC2 
observed in in vivo experiments results from the fact that Mot1 catalyzes the dissociation not 
only of TBP but also of TBP–NC2 complexes from the promoter sites. The exact role of NC2 
in this setting is not entirely clear, but this additional factor appears to function as a marker of 
nonproductive TBP complexes poising them for Mot1 action, e.g. on intragenic regions [30], 
[32].  
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5.2 The latch plays crucial role in dissociation mechanism 
 
The latch region has been initially characterized as a nonconserved structural element with 
the length largely varying between the species, which directly binds TBP’s concave surface 
[47]. In this manner, the latch resembles the TAND1 region of the biggest subunit of TFIID 
complex, TAF1 [148]. Both elements prevent TBP–DNA association in a relatively 
unspecific manner structurally mimicking DNA moiety. Deletion of the latch impairs the 
dissociation process of the Mot1–TBP–DNA complex. However, in contrast to TBP–DNA 
substrates, TBP–DNA–NC2 complexes are disrupted by Mot1 only in the presence of the 
latch region and show resistance to premature ATP-independent latch-dependent dissociation 
of the complex. Therefore, in the presence of NC2, the latch seems to play an important 
functional role in the dissociation mechanism catalyzed by Mot1. 
In the Mot1NTD–TBP–DNA–NC2 crystal structure the latch region is disordered. 
Similarly, the CX-MS analysis implies that this region does not exclusively bind to a 
particular region of the complex. If the latch was ordered, due to its small size (~50 residues) 
it would not have been possible to localize it in the negative stain EM map. Interestingly 
however, many crosslinks between Mot1’s latch and Mot1CTD were detected for all CX-MS 
data sets, constituting surprisingly high subset of detected linkages. The N-terminal part of 
yeast Mot1 has been already proposed to inhibit Mot1CTD action via electrostatic interactions 
under physiological conditions [46]. Similar mechanisms have been described for other 
Swi2/Snf2 members; for example the chromodomains of Chd1 and “leucine latch motif” of 
CSB localized upstream from the Swi2/Snf2 domains were shown to sterically modulate the 
ATPase activity as an autoinhibitory element and act in response to substrate recognition 
[54], [149]. Intriguingly, the ATPase activity of the Mot1∆latch mutant, in contrast to the WT 
protein, is not stimulated by TBP, regardless of the presence of NC2 ([47] and data not 
shown). Moreover, the latch contains Mot1’s nuclear localization signal, which becomes 
functional only after Mot1 association with TBP [43]. Therefore, the link between Mot1 
conformational changes occurring upon association with TBP point toward a possibility that 
the latch might directly function as an autoinhibitory element or that its interaction with TBP 
is indirectly modulated by such a mechanism. 
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5.3 Mot1 initially alters protein substrate–DNA interaction in an ATP-
independent way 
 
Mot1, apart from being an essential global transcriptional regulator serves as an attractive 
model system for structural and mechanistic studies of Swi2/Snf2 enzymes. Currently, 
different models are considered to explain how Mot1 catalyzes the disruption of TBP–DNA 
complexes: a) by inducing a conformational change of TATA DNA via the interaction 
between upstream DNA (i.e. DNA “handle”) and Mot1CTD; b) by DNA translocation 
mechanism, where, according to the general model proposed for all Swi2/Snf2 family 
enzymes, Mot1 would act as a molecular “snowplow” pushing or pulling off TBP from the 
promoter; or c) by alteration of TBP–DNA affinity either by a direct influence on TBP 
molecule or, alternatively, TATA box DNA itself. Several changes reported for the E. cuniculi 
Mot1NTD–TBP–DNA–NC2 complex structure, in comparison to the “product” Mot1NTD–TBP 
and “substrate” TBP–DNA–NC2 states, provide important insights into the early stage of the 
Mot-catalyzed reaction. Additional structural information derived from the EM and CX-MS 
analyses of the complex formed in the presence of the full-length Mot1 additionally extend 
some of these observations. 
 First, in comparison to the “product” state, “substrate”-bound Mot1NTD covers almost 
the whole convex site of TBP. This significantly enhanced contact suggests that Mot1, in 
order to remove TBP from DNA, might require a tighter grip on TBP. Interestingly, the 
expanded interface implies a direct interaction between the Mot1NTD’s insertion domain and 
the TBP’s N-terminal tail which, although included in the crystallization construct, was 
unfortunately not visible in the electron density. Interestingly enough, although this part of 
TBP’s polypeptide chain is evitable [150], it was shown to regulate TBP–DNA binding 
behavior and promote the formation of so-called “unbent” TBP-DNA species, which are 
much less stable than normal “bent” complexes [59], [92]. Apart from a possible influence of 
TBP’s N-terminus on Mot1-catalyzed reactions, also the region extending beyond the helix 
H5 of NC2β also contributes to the new Mot1NTD–NC2 interface. Interestingly, the QA-rich 
NC2β C-terminal fragment of human NC2β, although not required for TBP binding, was 
shown to be required for the repression, but not activation of transcription in vitro [99], [113]. 
Moreover, this part of the NC2β polypeptide representing a repression domain was found to 
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be a target of phosphorylation in vivo [151]. Similarly to TBP’s N-terminus, however, this 
part is not well characterized in the electron density. The observation that both TBP’s and 
NC2β’s repressive elements are in a direct proximity to the α-helical insertion domain of 
Mot1 raises intriguing possibility that this element does not only play a structural role. This 
region inserted between the HEAT repeats is characteristic to Mot1 and is conserved among 
the orthologs. The functional role of this part of the protein still awaits further 
characterization.  
 Second, in the Mot1NTD–TBP–DNA–NC2 complex crystal structure the DNA region 
flanking the TATA box promoter in the 5’ direction according to the “top” strand (i.e. 
upstream) appears to be altered, if this region is compared to the DNA trajectory in the 
“substrate” TBP–DNA–NC2 complex as well as other TBP–DNA complexes. Although, as 
already stressed in the Results section, both ends of the DNA substrate in the crystal structure 
are partially disordered and involved in the formation of the crystal contacts. Therefore, the 
arrangement of the DNA trajectory in the upstream part can be partially affected by DNA–
DNA interactions within the crystal lattice and, therefore, Mot1NTD-induced changes in DNA 
conformation might be overrepresented. However, these presence of “straightened” DNA—
which is consistent with increased lateral mobility—is in a full agreement with the results of 
single-molecule FRET experiments, which have shown that S. cerevisiae Mot1–TBP–DNA 
complexes in the absence of any nucleotide or in the presence of AGS and ALF are flexible 
due to equilibrium between bent and unbent DNA states [88]. Thus, Mot1NTD-induced 
changes in DNA conformation might be as well over- as underrepresented. Importantly for 
this discussion, Mot1-induced dynamic DNA behavior in these TBP–DNA complexes was 
observed on DNA templates which were too short to directly contact Mot1CTD, i.e. having 
only 3 bp in the upstream region. Several earlier studies also reported that Mot1 might 
change TBP–DNA interaction and that this process is not linked to any ATP-related 
conformational change of the ATPase domain; mechanically forced transient alteration of the 
TBP–promoter affinity would for example explain why Mot1 alters the DNase I digestion 
protection pattern of TBP even in the absence of ATP [8], [59], [70] and is not able to 
dissociate TBP from DNA with I–C-substituted TATA region [45]. Intermediate state protein–
DNA complexes, in which duplex DNA is distorted prior to ATP hydrolysis have been 
reported for SF1 helicases, e.g. in case of PcrA–DNA complexes [83]. Strikingly, Mot1-
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accociated TBP also loses the ability to discriminate between classical and mutated TATA 
sequences [49], [87]. Similarly, BTAF1 is able to induce DNA binding for the majority of the 
DNA-binding surface TBP mutants which are defective both for BTAF1 and DNA binding in 
solution [49]. Remarkably, ATP analogs were shown to convert Mot1–TBP complexes into a 
form capable of binding to DNA [48]. Thus, numerous in vitro experiments suggest that after 
Mot1 binding the TBP–DNA interface is altered. Analogously to Mot1, NC2 also induces 
dynamic behavior in the TBP–DNA interface, thereby enabling TBP to laterally move on 
core promoter DNA without its dissociation although DNA conformational changes have not 
been seen in the TBP–DNA–NC2 crystal structure [114]. Therefore, “pre-straightened” 
Mot1-targeted TBP–DNA–NC2 complexes might facilitate more efficient substrate 
recognition or dissociation. 
Third, as judged from the Cα root mean square deviation between the analyzed TBP 
structures, TBP conformation when bound to the TATA DNA in the presence of Mot1 and 
NC2 is somewhat distinct to that of TBP bound to TATA DNA alone, and rather similar to 
TBP bound to Mot1 alone (“product” complex). The observed changes are, however, small 
and are of borderline significance, but the trend is consistent. On the other hand, even 
minimal Mot1-dependent alterations might already have a critical impact on TBP–DNA 
interaction, especially that the severely bent TATA box sequence itself might accelerate this 
process acting as a “spring” for rapid release of TBP [152]. In this context interesting is that 
the association of Mot1 with TBP–DNA–NC2 seems to disrupt the NC2β–DNA contact site 
at H4. Remarkably, H4 is moved towards TBP and “bumps” into TBP’s C-terminal stirrup. 
This is particularly interesting, since two pairs of phenylalanine side chains, which are 
primarily responsible for introducing the dramatic change of the TATA element 
conformation, ale localized at or near the TBP’s stirrups [91]. Thus, Mot1 might indirectly 
destabilize TBP-induced kink in DNA via altering NC2 conformation.  
 Forth, in line with the hypothesis that Mot1 could directly contact the TATA box DNA 
in the presence of TBP [49], [59], the structural analysis presented here points towards a 
possibility for a Mot1NTD–DNA interaction. This is additionally strengthen by the observation 
Mot1CTD is not the only part of the Swi2/Snf2 enzymes that form direct contact to DNA 
[153]. Since Mot1CTD does not contact TBP [45] and the latch–DNA interaction can be also 
rather excluded ([48] and data not shown) the Mot1 contribution to this interaction could be 
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mediated via the conserved and negatively charged N-terminus of the HEAT repeat domain 
(HR 1–2). Although this region does not form direct contacts with DNA, it resides in a close 
proximity to the DNA in the E. cuniculi Mot1NTD–TBP–DNA–NC2 complex structure. 
Interestingly, the deletions within the fist 100 residues result in inviablitiy or in a dominant-
negative phenotype in yeast [48], which would suggest that this region likely forms important 
contacts in the context of the full-length protein, i.e. with TBP or the ATPase domain. 
 Fifth, the conclusions drawn from the interpretation of the crystal structure 
determined in the presence of truncated Mot1 are supported by the CX-MS and negative stain 
electron microscopy studies of the complex in the presence of Mot1CTD. The results presented 
in this work show that Mot1CTD, when bound to an ATP analog, directly contacts the NC2HF 
domain. This interaction site, next to the Mot1NTD–TBP–NC2β contact site could serve as 
anchor points, which together would be well suited to alter the TBP–NC2 and TBP–DNA 
interactions, at the same not weakening the Mot1NTD–TBP interaction [43].  
 Sixth, according to the EM reconstruction, Mot1CTD–DNA association in the presence 
of ABF does not seem to introduce large changes to the upstream DNA conformation 
relatively to the TATA box-bound TBP, which would imply that Mot1 does not exploit 
upstream DNA “handle” in order to introduce e.g. DNA twisting. Instead, as described 
before, the observed modifications of protein–DNA interactions are explicitly a result of 
Mot1NTD binding. The limited resolution of the EM reconstruction does not, however, 
exclude that some additional rearrangements not present in the crystal structure might occur, 
especially that more extensive compaction of the HEAT repeat array is observed. Therefore, 
it cannot be ruled out that, due to the binding of Mot1CTD to the upstream DNA, 
rearrangements at the TATA box are even more pronounced compared to the situation 
observed in the Mot1NTD–TBP–DNA–NC2 crystal structure. Moreover, many crosslinks 
between Mot1CTD and TBP detected in all CX-MS experiments, which cannot be explained 
by the proposed model, were detected. Unfortunately, parallel attempts to obtain negative 
stain reconstructions of the Mot1–TBP–DNA–NC2 complex in ADP- or AGS-bound state 
were ineffective. Therefore, the potential differences between to nucleotide and nucleotide-
bound states could not have been fully investigated. The complex might be not uniform 
enough when bound to these nucleotides to allow effective sorting of the negatively stained 
particles. This might additionally imply that additional large rearrangements occur through 
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Figure 30. General model for Mot1-catalyzed dissociation. 
The binding of Mot1 (Mot1NTD in yellow, RecA1 in pink, RecA2 in purple, latch shown in magenta as cylinder) 
induces destabilizing conformational changes in the TBP–DNA–NC2 complex (TBP is shown in blue, and the 
NC2 heterodimer is shown in dark and light green). Subsequently, the ATPase domain stably engages upstream 
DNA and its ATP hydrolysis-mediated functions directed in the upstream direction cause the final release of 
TBP and NC2 from DNA.  
 
ATP hydrolysis and phosphate release.  However, considering the relative small size of the 
proteins analyzed in this study as well as the resolution limits of the negative stain EM and 
CX-MS methods, more detailed information is not available, e.g. from cryo-EM or higher-
resolution X-ray analysis. 
Taken together, the data presented here suggest the following model for Mot1 action, in 
the first step, TBP’s and NC2’s interaction with DNA is destabilized by Mot1 binding.  Mot1 
first acts on the substrate complexes enforcing a state, in which TBP is incompetent to bind 
to the TATA box anymore. This process is not directly coupled to ATP hydrolysis and does 
not necessarily results in TBP removal from DNA (Figure 30). Although E. cuniculi 
Mot1NTD binding to TBP–DNA is in principle sufficient to displace TBP from DNA S. 
cerevisiae, full-length Mot1 complexes are fairly stable on longer DNA templates in vitro 
[59], [87]. In the presence of NC2, changes in the TBP–DNA interaction also occur, but the 
formation of the Mot1NTD–NC2 clamp in Mot1NTD–TBP–DNA–NC2 complexes does not 
allow premature TBP–DNA dissociation observed for Mot1NTD–TBP–DNA complexes in 
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EMSA experiments. Subsequent Swi2/Snf2 ATPase-dependent remodeling step triggered by 
ATP hydrolysis enables dissociation of the “primed” complexes from upstream DNA in an 
ATP-dependent process.  
 
 
5.4 Mot1 and other Swi2/Snf2 enzymes  
 
Mechanistic understanding of how ATP hydrolysis is coupled to protein–DNA 
rearrangements catalyzed by Swi2/Snf2 enzymes is very limited. The interpretation of the 
structural and biochemical data presented here does not entirely addresses this issue, 
especially that the Mot1 construct used for the determination of the Mot1NTD–TBP–DNA–
NC2 crystal structure lacked Mot1CTD and, therefore, the most valuable high-resolution 
information is still largely absent. However, low-resolution negative stain imaging, 
crosslinking and activity experiments performed on the full-length Mot1-containing Mot1–
TBP–DNA–NC2 complex presented in this work revealed several interesting findings which 
show similarities and dissimilarities between Mot1 and other Swi2/Snf2 family members. 
Analysis of the CX-MS data analyzed in this work revealed that the nucleotide state 
of Mot1CTD has a crucial impact on the conformation of the Swi2/Snf2 ATPase domain. This 
is fully consistent with the conformational changes described for Sulpholobus solfataricus 
Rad54-like Swi2/Snf2 enzyme occurring during the ATP hydrolysis. SsoRad54-like ATPase 
undergoes drastic conformational alterations involving the changes in the relative 
reorientation of the two RecA-like subdomains on DNA substrates even in the absence of 
ATP [138]. Analogously, Mot1 can freely adopt the active conformation in solution even in 
the absence of ATP and, due to such conformational heterogeneity, is able to dissociate a 
fraction of TBP–DNA complexes; however, this effect is not observed for the “hinge” mutant 
of Mot1, which is believed to be impaired in the conversion of the active and inactive ATPase 
state [59].  
The most interesting uncovered parallel to chromatin remodelers is the fact that 
Mot1CTD, particularly the RecA2-like subdomain, is in a direct proximity to NC2HF and the 
upstream DNA. A direct involvement of the ATPase domain in nucleosomal substrate 
recognition as well as in the coupling of ATP hydrolysis to chromatin remodeling function 
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has been shown [154]–[156]. More detailed information about the position to which ATPase 
engages nucleosome is based on site-specific crosslinking experiments and nucleosome 
sliding experiments using gapped DNA substrates, which have shown that the Swi2/Snf2 
domain of chromatin remodelers directly binds to nucleosome at superhelical location 2 
(SHL2)—two turns away from the dyad axis [154], [157]. Notably, the position of Mot1CTD 
relative to NC2HF in our CX-MS- and EM-derived models is analogous to the association of a 
Swi2/Snf2 domain bound at SHL2, i.e. in a direct proximity to the H3/H4 histone pair 
slightly away from the dyad (Figure 31). Therefore, is appears that Mot1 and Swi2/Snf2 
chromatin remodelers likely act via related mechanism and they share the ability to 
specifically recognize a histone fold protein–DNA complex as a substrate.  
 
 
Figure 31. Binding of Swi2/Snf2 ATPase to its histone fold-DNA substrate. 
Left: the ATPase domain of a chromatin remodeler specifically recognizes to the nucleosome particle at 
superhelical location 2 (SHL2), two turns from the dyad (marked with the red dot). This enables ATPase domain 
to specifically recognize e. g. histone H4 tail modifications. Histones H2A, H2B, H3 and H4 are shown in light 
cyan, dark cyan, yellow and coral, respectively. The protein and DNA parts symmetric according to the dyad 
axis were omitted. Right: Localization of Mot1CTD segment from the EM reconstruction (purple transparent 
density) of Mot1–TBP–DNA–NC2 complex relatively to TBP and NC2HF. The DNA particle presented here 
was superimposed based on the crystal structure of transcription factor NF-Y with DNA, which exhibits 
nucleosome-like curvature [109]. The position on DNA analogous to SHL2 on the nucleosome is also marked 
with the red dot.  
 
Notably, the remodeling activity of Swi2/Snf2 chromatin remodelers in some cases 
requires the presence of histone tails or their modifications or can be modulated in response 
to the modifications of remodeler subunits themselves [53], [158]–[160]. Thus, the 
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unexpected common feature shared between Swi2/Snf2 family remodeling enzymes and 
Mot1 to remodel a histone fold–DNA complex point out at a possibility that some 
modifications of NC2 subunits might affect Mot’s affinity to its substrate. Indeed, both NC2 
subunits, similarly to histones, have been shown to undergo various posttranslational 
modifications like phosphorylation, acetylation, methylation and ubiquitination in vivo [49], 
[151], [161]–[172]. The Mot1 region, which could be primarily responsible for “reading the 
NC2 code”, also remains to be defined. For example, Mot1’s insertion domain would be well 
positioned to response to modifications occurring on the C-terminus of NC2β. In analogy to  
nucleosomal substrates, Mot1CTD itself could recognize modifications occurring on N-
terminal tail of NC2α and/or NC2β. In the E. cuniculi system, NC2 does not seem to 
stimulate Mot1’s ATPase activity, its TBP–DNA dissociation rate, or affinity to the substrate 
complexes ([89] and data not shown). Analogously, the ATPase activity of SWI/SNF and 
RSC remodeling complexes does not require intact nucleosomes for maximal stimulation 
[53]. In any case, the impact of NC2 modifications on Mot1 activity needs to be further 
investigated. 
The ATPase activity of chromatin remodelers is stimulated both by naked DNA and 
nucleosomal substrates [53].  In contrast, the ATPase activity of Mot1 has been shown to be 
activated exclusively by TBP or TBP and DNA synergistically but not by DNA alone [9], 
[14], [45]–[47]. However, yeast Mot1CTD can bind dsDNA on its own in a nucleotide-
dependent manner [88] and the activity of the full-length Mot1 reaches the one of Mot1CTD 
under very high salt or nonphysiological pH conditions [46]. Thus, the N-terminal part of 
Mot1 seems to have a regulatory effect on DNA binding, which is unmasked only upon the 
association with TBP [46]. The influence of DNA on the ATPase activity of Mot1CTD has not 
been investigated.  
The majority of SF2 members include accessory domains formed as N- or C-flanking 
regions or as inserts within the core ATPase domain [173]. Interestingly, most of the 
crosslinks between Mot1CTD and NC2HF map to the protrusion region of the RecA2-like 
subdomain, the major family-specific insertion site of Swi2/Snf2 ATPases [52]. Interestingly, 
crosslinks between histones H2A/H2B and RecA2 lobe of Ino80, the catalytic subunit of 
INO80 remodeling complex were detected [174]. A general role of the insertion regions of 
Swi2/Snf2 ATPases in distorting local DNA structure has already been proposed [175]. 
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Intriguingly, such an extended interaction could suggest a direct role for insertions in 
inducing DNA distortion. Remarkably, SWI/SNF has been suggested to disturb histone–DNA 
contacts by wedging the RecA2 lobe between DNA and protein substrates [154]. This has 
been, however, not observed in the case of ISWI remodeler [154]. Therefore, further 
structural studies on more Swi2/Snf2 members would be necessary to address this issue in 
more detail.  
Although Mot1 shares some similarities with chromatin remodelers and other 
Swi2/Snf2 ATPases, the findings presented here disfavor the hypothesis of DNA tracking-
related mechanism of action and show that Mot1 rather locally disrupts the DNA interaction. 
Although the formation of the Mot1–NC2 “clamp” would be appropriate for sliding along 
DNA track, unobstructed DNA ends were shown not to be required for efficient Mot1-
catalyzed dissociation of TBP/TBP–NC2 from DNA substrates [85], [89]. Accounting for 
slight rearrangements within the HEAT repeats, the CX-MS and EM analyses imply that 
Mot1CTD would primary contact the non-TATA box-containing strand. According to the 3’–5’ 
tracking direction shown for some Swi2/Snf2 remodelers, this would suggest that Mot1 could 
track over very short distances, e.g. one or two base pushing the substrates from the promoter 
 
 
Figure 32. Remodeling of substrate protein–DNA complexes by Mot1 and nucleosome remodelers.  
Left side: The binding of Mot1 (Mot1NTD in yellow, Swi2/Snf2 ATPase domain in purple) induces 
destabilization of TBP–DNA and NC2–DNA interactions (TBP is shown in blue, NC2 is represented by a green 
shape). Right side: a Swi2/Snf2 remodeler bound to nucleosome. The DNA-binding domain engages DNA at 
the nucleosome entry site. In both cases, the ATPase domains in a similar manner specifically recognize their 
histone fold–DNA substrates. ATP hydrolysis-mediated conformational changes lead to short-range 
translocation of Mot1 into upstream direction from the TATA box causing the final release of TBP and NC2 
from DNA. Analogously, the ATPase domain of a nucleosome remodeler actively pumps the DNA in 3’–5’ 
direction, according to the tracking strand. The direction of DNA movement is represented by the black arrows.  
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into the downstream direction. This is, therefore, quite distinct to long-range tracking shown 
for RSC remodeling complex reaching up to 70 bp [73] or 40 bp for ISWI [71]. Moreover, 
only fully duplexed upstream DNA supports efficient Mot1–TBP–DNA complex formation 
and its dissociation [70]. This is again in contrast to other dsDNA translocases which are 
active on ssDNA substrates and translocate predominantly along one of the strands [71], [73], 
[75]. Thus, it appears that all Swi2/Snf2 ATPases undergo similar ATP-dependent 
conformational changes but they exploit them in a different way in response to various 
stimuli. 
 
 
5.5 Novel roles for Mot1 and NC2β? 
 
Although the function of NC2α and NC2β in the heterodimeric complex is supported by 
large body of in vitro and in vivo data, several independent studies postulated that NC2α and 
NC2β polypeptides might function as separate factors [94], [97], [99], [106], [121]–[123]. 
Many results are not entirely conclusive in this matter, since very often no direct comparison 
of the effect of either subunit on transcription process was monitored and the effects 
observed for NC2α or NC2β were assigned to the function of the whole complex. Thus, in 
the light of the accumulating data, such discrimination seems to be necessary for the precise 
data interpretation in future experiments.  
 The initial analysis of the E. cuniculi Mot1NTD–TBP–NC2β complex crystal structure 
represents a distinct, uncharacterized form of Mot1–NC2β assembly. NC2β subunit is present 
in an unusually elongated conformation, which has not been reported for any histone fold 
protein subunit. However, NC2α and NC2β are the only subunits of a histone fold-containing 
protein complex, which were suggested to function as separate subunits. As described in the 
results section, the observed novel interaction between TBP, Mot1NTD’s latch and NC2β’s H3 
and H4 would be only possible if Mot1 was a functional dimer. Although multimierization of 
Mot1NTD–TBP–NC2β complexes was observed in gel filtration experiments, due to 
Mot1NTD’s preference to crystallize in a particular configuration it is difficult to judge if the 
observed arrangement is relevant or whether it is a result of nonspecific hydrophobic 
interactions of the crystal lattice. Clearly, structural analysis of the complex in the presence 
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of full-length Mot1 would be necessary to unambiguously answer some of the questions 
regarding functional relevance of the presented Mot1NTD–TBP–NC2β crystal structure.  
 What could be the physiological function of Mot1 and NC2β bound to TBP? This 
aspect is particularly intriguing, since NC2 is preferentially imported to the nucleus as a 
preassembled complex [124]. Remarkably, Mot1 was reported to be responsible for 
ATP-dependent dissociation of the NC2 heterodimer [97]. ATP-independent disassembly of 
NC2, which is otherwise very resistant to extreme pH and salt conditions, was also observed 
in the presence of Mot1 for E. cuniculi proteins (not shown). Dissociation of NC2 into 
separate subunits would unmask NES of NC2β polypeptide resulting in different distribution 
of α and β subunits in the cell [124]. Remarkably, in the Mot1NTD–TBP–NC2β structure the 
NES stretch of the NC2β subunit is localized at the interface between TBP and Mot1's latch. 
Therefore, Mot1 apart from catalyzing the dissociation of TBP and NC2 from DNA might be 
additionally responsible e.g. for blocking the export of NC2β from the nucleus. It is, 
however, not clear if Mot1NTD–TBP–NC2β represents transcriptionally active ("loading 
complex") or inactive form ("dead-end" complex) of TBP. Certainly, more experiments 
including genome-wide ChIP and in vitro activity assays are required to understand the 
function of Mot1–NC2β assemblies. Additionally, analogous analysis of the NC2α subunit 
and the impact of posttranslational modifications would be necessary. 
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6. EXPERIMENTAL PROCEDURES 
 
 
6.1 Materials 
 
All common chemicals were obtained from Merck, Sigma–Aldrich or Carl–Roth, unless 
stated otherwise.  
 
6.1.1 Media and antibiotics 
 
2xYT, Lysogeny Broth (LB-Lennox) and Terrific Broth (TB) media used for culturing of the 
E.coli strains were prepared as described in Table 4. For the generation of solid media, 1.5% 
agar (w/v) was added. Sf21 insect cells were grown in Sf-900 III serum-free medium (Life 
Technologies). High Five insect cells were grown in Express Five serum-free medium (Life 
Technologies) prepared according to the manufacturer’s instructions. 
 
Table 4. Media used for culturing E.coli strains.  
Compound 2xYT LB TB 
Tryptone 16 g 10 g 12 g 
Yeast extract 10 g 5 g 24 g 
NaCl 5 g 10 g - 
Glycerol - - 4 mL 
NaOH pH ~ 7.0 pH ~ 7.0 - 
0.17M KH2PO4 
0.72M K2HPO4 
(sterile solution) 
- - 100 mL 
Distilled water Up to 1000 mL 
 
Antibiotics used for the selection of plasmid-carrying E. coli clones are listed in Table 5. The 
stocks were used as 1:1000 (v/v) dilutions. Insect cell media were supplemented with 10 
µg/mL gentamicin (Roth) and 10 mM L-glutamine (Invitrogen). 
 
EXPERIMENTAL PROCEDURES 
84 
Table 5. List of antibiotics used for the maintenance of E. coli cultures.  
Compound Stock concentration [mg/mL] solvent 
ampicillin 100 water 
chloramphenicol 34 ethanol 
kanamycin 50 water 
tetracycline 10 ethanol 
gentamicin 7 water 
 
 
6.1.2 Strains 
 
Table 6. E. coli strains. 
Strain Supplier Genotype 
XL1 blue Stratagene 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac 
[F´proAB lacIqZ∆M15 Tn10 (Tetr)] 
Rosetta (DE3) Novagen F– ompT hsdSB (rB– mB-) gal dcm (DE3) pRARE2 (CamR) 
B834 (DE3) Novagen F– ompT hsdSB(rB– mB-) met gal dcm (DE3) 
DH10MultiBac  Redbiotech 
F– mcrA ∆(mrr-hsdRMS-mcrBC) Φ80lacZ∆ 
M15 lacX74 recA1 endA1 araD139 (ara, leu)7697 galU galK 
∆– rpsL nupG/pMON14272/pMON7124 
 
Table 7. Insect cells.  
Strain Species Supplier 
IPLB-Sf21-AE (Sf21) Spodoptera frugiperda  Life Technologies 
BTI-TN-5B1-4 (High Five) Trichoplusia ni Life Technologies 
 
 
6.2 Molecular biology methods 
 
All vectors were obtained from Petra Wollmann (Hopfner Group, Gene Center, LMU, 
Munich). For this study, TEV protease cleave sites were newly introduced between the 
protein sequences and the expression tags for all plasmids used, with single exception for 
pET28a-TBPfl vector, for which TEV cleavage site substituted thrombin cleavage site. 
Oligonucleotides used for cloning (Table 8) were purchased from Metabion in a desalted 
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purity grade and in a lyophilized form and before use were diluted in distilled water. 
 
Table 8. Expression plasmids. 
Name Plasmid Encoded 
sequence 
Restriction 
site 
Tag 
pET28TEV-TBPfl pET28a E. cuniculi TBP 
1–198 
NcoI/none N-H6 (TEV) 
pETDuetTEV-NC2β-NC2α pET-
Duet1 
E. cuniculi NC2β 
1–147 (MCS1) 
None/none 
(MCS1) 
N-H6 (TEV) 
(MCS1) 
E. cuniculi NC2α 
1–95 (MCS1) 
None/XhoI 
(MCS2) 
None (MCS2) 
pETDuetTEV-NC2β-NC2α∆C pET-
Duet1 
E. cuniculi NC2β 
1–147 (MCS1) 
None/none 
(MCS1) 
N-H6 (TEV) 
(MCS1) 
E. cuniculi NC2α 
1–79 (MCS1) 
None/XhoI 
(MCS2) 
None (MCS2) 
pFBDM-Mot1(TEV) pFBDM E. cuniculi Mot1 
1–1256 
None/NotI 
(MCS1) 
N-H6 (TEV) 
pFBDM-Mot1NTD(TEV) pFBDM E. cuniculi Mot1 
1–778 
None/NotI 
(MCS1) 
N-H6 (TEV) 
pFBDM- Mot1NTD∆L (TEV) pFBDM E. cuniculi Mot1 
1–778 ∆97–137 
None/NotI 
(MCS1) 
N-H6 (TEV) 
pFBDM-Mot1∆L (TEV) pFBDM E. cuniculi Mot1 
1–1256 ∆97–137 
None/NotI 
(MCS1) 
N-H6 (TEV) 
 
Table 9. Oligonucleotides used for cloning. 
Name Sequence (5’ – 3’) 
TBP_28TEV_F AAACCTGTATTTTCAGGGACATATGGACGCACCAGATATTTCTTATGAGCA
TC 
TEV_R  TGAAAATACAGGTTTTCGCCGCTGCTGTGATGATGATGATGATG 
Mot1_TEV_F AAACCTGTATTTTCAGGGACATATGAATAGATTAGAGAAGTTCTTCACCA
CACTGAAC 
Duet_NC2b_TEV_F AAACCTGTATTTTCAGGGACATATGAATATGGAGAAAAACGATGACGAAA
ACACATTACC 
NC2a_P80*_F TCGTGCTACCGAATCTGATTAAAAATTTGCGTTCCTCAA 
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6.2.1 Polymerase chain reaction (PCR) 
 
Standard PCR reactions were performed using Phusion Flash High-Fidelity PCR Polymerase 
Mix (Thermo Scientific). Reaction mixtures were prepared accordingly to the manufacturer’s 
protocol. The temperature of the annealing step was set to a value which was usually 3-5ºC 
lower than the predicted melting temperature of the used primiers. The melting temperature 
of the primers was estimated with Oligo Calc online tool (available at http-
//www.basic.northwestern.edu/biotools/oligocalc.html). Digestion of the methylated template 
DNA was performed with DpnI (Thermo Scientific) by adding 1 µL of the enzyme directly to 
the PCR reaction followed by overnight incubation at 37ºC. Finally, PCR products were 
purified using Nucleo Spin Extract II Kit (Macherey-Nagel) and eluted in distilled water 
preheated to 50°C.  
 
 
6.2.2 Site-directed mutagenesis 
 
The procedure was performed according to QuikChange II Site-Directed Mutagenesis Kit 
Protocol (Stratagene) using Pfu Ultra DNA Polymerase (Stratagene). The primers 
introducing single-amino acid changes in the protein sequences were designed using Primer 
X online tool (http://www.bioinformatics.org/primerx/cgi-bin/protein_1.cg). After whole-
plasmid PCR reaction, digestion of the methylated template DNA was performed with DpnI 
(Thermo Scientific) by adding 1 µL of the enzyme directly to the PCR reaction followed by 
overnight incubation at 37ºC. The reaction mixture was then directly used for transformation 
into E. coli. 
 
 
6.2.3 In-Fusion cloning reaction 
 
Molecular cloning was performed using In-Fusion Advantage PCR Cloning Kit (Clonetech). 
This method allows joining multiple pieces of DNA that have 15 bases of complementarity at 
their ends without the use of any restriction enzymes. The target insertion sequence was 
placed on the 5’ ends of both cloning primers and the first 15 bp were complementary (see 
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Table 9, underlined). The In-Fusion cloning mixture was prepared according to the 
producer’s manual using ~50 ng of isolated vector DNA. This protocol was used to introduce 
TEV cleavage recognition sites between the expression tags and proteins. 
 
 
6.2.4 Transformation into E. coli 
 
Competent cells (50–100 µL in a 1.5 mL microcentrifuge tube) were first thawed on ice. 
Subsequently, 5 µL of target DNA were added to the competent cells and gently mixed by 
tapping. The mixture was incubated for 15 minutes on ice. Heat shock was performed for 45 
s at 42°C, after which cells were chilled on ice for 1 min. Next, 400 µL of room temperature 
LB medium was added and the cells were recovered at 37°C for 1 hour (600 rpm). Finally, 
the cells were spread onto solid LB medium containing appropriate antibiotics enabling 
positive selection of successfully transformed clones. Plates were incubated overnight at 
37°C.  
 
 
6.2.5 Plasmid DNA isolation and sequencing 
 
Plasmid DNA isolation of single-colony transformants was performed using NucleoSpin 
Plasmid EasyPure  kit (Macherey-Nagel) eluted in preheated distilled water. Plasmid DNA of 
the selected clones was sequenced by Eurofins.  
 
 
6.2.6 Transposition into bacmid and bacmid DNA isolation 
 
For the transposition of the donor plasmid into the bacmid, DNA was transformed into E. coli 
DH10MultiBac competent cells. For that, 100 µL of the competent cells were thaw on ice 
and transferred into a 15 mL polypropylene tube. Approximately 1 µg of the pFBDM 
plasmid with a gene of interest was added to the cells and incubated on ice for 30 min. After 
the incubation the cells were heat-shocked by transferring to a water bath heated up to 42°C 
for 60 s and cooled down on ice for 1 min. Subsequently, 600 µL of 2xYT medium without 
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antibiotics was added and the cells were placed in a shaking incubator for 6–16 h at 37°C 
(200 rpm). After the recovery, the cells were spread onto agar plates containing kanamycin, 
gentamicin and tetracycline at 1:1000 dilutions of the stocks listed in Table 5, as well as X-
Gal (100 µg/mL) and IPTG (0.5 mM). The plates were incubated for 2–3 days at 37°C. 
Afterwards, white colonies containing recombinant bacmid were streaked to confirm the 
phenotype. Positive colonies were inoculated into 5 mL of 2xYT medium containing 
kanamycin, gentamicin and tetracycline (Table 5) and grown overnight in a shaking 
incubator at 37°C (200 rpm). Bacmid DNA was isolated using isopropanol precipitation 
protocol according to the instructions included in Bac-to-Bac Baculovirus Expression 
Systems user manual from Invitrogen. 
 
 
 
6.3 Protein expression and purification 
 
6.3.1 Insect cell expression system 
 
Insect cell expression system was used to express N-terminally His6-tagged full-length E. 
cuniculi Mot1 (1–1256) and Mot1NTD (1–778), E. cuniculi Mot1∆latch (1–1256, ∆97–137) and 
Mot1NTD∆latch (1–778, ∆97–137). 
 
Propagation of the virus in the Sf21 insect cells 
200 µl of Sf-900 III SFM medium (Life Technologies) was mixed with 3 µl of FuGene 
transfection reagent (Promega) and with 1–3 µg of isolated bacmid DNA. Prepared mixtures 
were incubated for 45 min at room temperature. In the meantime, 2 mL of Sf21 cells per one 
transfection reaction at 4·105/mL suspended in Sf-900 III SFM medium were prepared and 
left at 27.5°C for 30 min. After the incubation times finished, transfection mixtures were 
added to the cells and incubated at 27.5°C. After 3 to 4 days the media containing P0 virus 
were collected and centrifuged at 3000 rpm for 15 min. The supernatants (2 mL) were added 
to 10 mL of Sf21 cells at 1·106/mL suspended in Sf-900 III SFM medium per each construct 
and incubated in a shaker at 27.5°C for 3 days. Next, the cells were counted and the cultures 
were centrifuged. Only the best-transfecting viruses were selected for further amplification. 
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The selection was based on the viability of the transfected cells after the incubation time as 
well as on the number of the cells and average cell diameter in comparison to the not 
transfected control culture. Therefore usually two independent transfection reactions were 
prepared for each construct and more potent virus was chosen on this stage for the final 
experiments. Chosen P1-containing media (0.02–2 mL) were added to 20 mL of Sf21 cells 
diluted at 4·105/mL in Sf-900 III SFM medium per each construct. The volume of the P1 
virus supernatant depended on the strength of the virus. The cultures were incubated in a 
shaker at 27.5°C for another 3 days. Afterwards the cells were counted and centrifuged at 
3000 rpm for 15 min. The supernatants containing strong P2 viruses were stored at 4°C.  
 
Protein expression 
0.5–1L of High Five cells at 1·106/mL cultured in Express Five medium (Life Technologies) 
was infected with P2 virus in 1:1000 ratio and harvested 60–72 h afterwards. Pellets were 
frozen in liquid nitrogen and stored at -80°C or the purification was performed directly after 
harvesting. 
 
Protein purification 
Harvested cells were disrupted by brief sonication (30 s, 50% power, 30% duration) in the 
lysis buffer A1 or A2 for full-length Mot1 and Mot1NTD, respectively. All the buffers used for 
the purification of the recombinantly expressed proteins are listed in Table 10. Soluble 
fraction was separated from the cell debris by centrifugation at 4° for 40 min at 15000 rpm. 
Supernatant was filtrated through a 45 µm filter (Merck Millipore) and loaded onto a gravity 
flow column with pre-equilibrated Ni-NTA beads (QIAGEN) at 4°. The flow-through 
fraction was reloaded onto the beads at least two more times. Unspecifically bound proteins 
were washed out extensively with buffer A and remaining fraction was eluted with elution 
buffer B. Elution fractions together with TEV protease (30:1 w/w) were dialyzed overnight 
against low salt ion exchange buffer C1 or C2 for full-length Mot1 and Mot1NTD, 
respectively. After the dialysis the sample was centrifuged for 15 min at 4 at 1x000g and 
applied onto a 5 mL HiTrapQ column (GE Healthcare). Bound proteins were eluted from the 
column using linear gradient of high salt buffer D1 or D2 for full-length Mot1 and Mot1NTD, 
respectively. Fractions containing protein of interest were concentrated to final volume of 3 
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mL (Merck Millipore) and loaded onto S200 16/60 gel filtration column pre-equilibrated in 
gel filtration buffer D. Protein fractions were concentrated to 10–20 mg/mL, pipetted as 15–
50 µl aliquots, frozen in liquid nitrogen and stored at -80°C. 
 
Selenomethionine labeling 
Selenomethionine labeling in insect cells was performed for N-terminally His6-tagged 
Mot1NTD construct. First, 100 mL of High 5 insect cell culture was adapted to Sf-900 II SFM 
medium (Life Technologies) by growing the cells from a starting concentration of 4·105/mL 
in a shaker for 4 days at 27.5°C. Subsequently, the cells were diluted to 1·106/mL in 0.5 L of 
Sf-900 II SFM medium and infected 1-750 v/v with P2 virus. The culture was grown for 12 h 
and centrifuged at 800rpm for 10 min. The cell pellet was resuspended in 0.5 L of Sf-900 II 
SFM medium supplied with 75 mg of L-cysteine (Sigma). After 4 h of methionine depletion 
the cells were centrifuged again and resuspended in 0.5 L of Sf-900 III SFM medium 
supplied with 75 mg of L-cysteine and 35 mg of L-selenomethionine (Acros Organics). The 
expression was carried out for another 48 h in a shaker at 27.5°C. The media were supplied 
with 1.4 µg/mL gentamicin. 
 
 
6.3.2 Escherichia coli expression system 
 
E. coli expression system was used to produce recombinant E. coli expression system was 
used to produce N-terminally His6-tagged full-length E. cuniculi TBP (residues 1–198), His6-
tagged full-length NC2β (residues 1–147) and to co-express His6-tagged full-length NC2β 
with an untagged version of full-length NC2α (1–95). His6-tagged full-length NC2β was co-
expressed from a plasmid carrying truncated NC2α construct (NC2α 1–79), which did not co-
purify. 
 
Protein expression 
The constructs were expressed in E.coli Rosetta (DE3) strain by inducing the expression 
from the lactose promoter by adding 0.5 mM IPTG (final concentration) to the medium. The 
induction was performed after the optical cell density measured at 600 nm reached 0.6–1.0. 
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The expression was carried out at 18°C for around 20 h (overnight).  
 
Protein purification 
Initial protein purification step for TBP was performed using buffer A3 and A2 for NC2α/β 
heterodimer. The resuspended cells were sonicated two times for 5 min (50% power, 30% 
duration) using a sonicator and centrifuged at 4° for 40 min at 15000 rpm. The supernatant 
was mixed with pre-equilibrated Ni-NTA beads (QIAGEN) and incubated for 2h at 4° in a 
batch mode. After the incubation the resin was loaded onto a gravity flow column and 
washed extensively with buffer A. Remaining proteins were eluted with elution buffer B. 
TEV protease was added to the elution fractions (30:1 w/w) to cut off the His6 tag. The 
sample was dialyzed overnight against low salt ion exchange buffer C2 and centrifuged for 
15 min at 4 at 1000g. Further purification was performed by ion exchange chromatography 
applying the sample on a 5 mL HiTrapS. Bound proteins were eluted from the column using 
a linear gradient of high salt buffer D2. Elution fractions were concentrated to a final volume 
of 3 mL by ultrafiltration (Millipore) and loaded onto S75 16/60 gel filtration column (GE 
Healthcare) pre-equilibrated in gel filtration buffer D. Protein fractions were concentrated to 
4-20 mg/mL, pipetted as 50 µl aliquots, frozen in liquid nitrogen and stored at -80°C. 
 
Table 10. Buffers used for the purification of the recombinantly expresses proteins. 
Name Content 
Lysis A1 50 mM Hepes, 300 mM NaCl, 5 mM Imidazole, 5% glycerol (v/v), 10 mM B-
ME, pH 7.5, Protease Inhibitor Cocktail Tablets, EDTA-Free (Sigma) 
A2 50 mM Hepes, 400 mM NaCl, 10 mM Imidazole, 10 mM B-ME, pH 7.5 
A3 50 mM Hepes, 1.5M NaCl, 10 mM Imidazole, 10 mM B-ME, pH 7.5 
Elution B 50 mM Hepes, 200 mM NaCl, 300 mM Imidazole, 10 mM B-ME, pH 7.5 
IEX low salt C1 20 mM Hepes, 100 mM NaCl, 2 mM DTT, 0.5 mM EDTA, 5% glycerol (w/w), 
pH 8.0 
C2 20 mM Hepes, 100 mM NaCl, 2 mM DTT, pH 8.0 
IEX high salt D1 20 mM Hepes, 1 M NaCl, 2 mM DTT, 0.5 mM EDTA, 5% glycerol (w/w), pH 
8.0 
D2 20 mM Hepes, 1 M NaCl, 2 mM DTT, pH 8.0 
Gel filtration E 20 mM Hepes 7.5, 200mM NaCl and 2mM DTT 
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Selenomethionine labeling 
The plasmids were transformed according to the standard protocol into E. coli Rosetta B834 
cells and plated on LB–agar plates. The 200 mL precultures were inoculated into LB media 
and grown overnight at 37° with continuous agitation. The main cultures were grown in 
Selenomethionine Medium Base supplemented with Nutrient Mix (Molecular Dimensions). 
Additionally, selenomethionine solution was added at a final concentration of 42 mg/L to the 
sterile medium prior to inoculation. The media and selenomethionine solution were prepared 
according to the manual supplied by the producers. The cultures were grown in a shaker (160 
rpm) at 37° until OD600 reached 0.4. Next, the temperature was set to 18° and the cultures 
were further grown until OD600 ≈ 0.7. The expression was initiated by adding IPTG at final 
concentration of 0.5 mM and carried out further at 18°C overnight. All of the media were 
supplemented with chloramphenicol and additional antibiotics dependent on the resistance-
coding expression plasmids. The applied protein purification protocols did not differ from the 
ones used for the purification of unlabeled proteins. 
 
 
6.4 Protein biochemistry 
 
6.4.1 Protein quantification 
 
Protein concentration was calculated based on UV absorbance at 280 nm using NanoDrop 
1000 spectrophotometer (Thermo Scientific). Due to high absorption of DNA at 280 nm, 
protein concentration of the protein–DNA complex samples was performed using Bio-Rad 
Protein Assay Dye Reagent Concentrate (BioRad) according to the manufacturer’s 
instruction, which is based on the Bradford method [176]. Bovine serum albumin (Roth) was 
used to generate the calibration curve.  
 
 
6.4.2 SDS-PAGE 
 
Protein sample analysis was performed using NuPAGE Bis-Tris Precast Gel system (Life 
Technologies) according to the manufacturer’s instructions. Prior to loading, the samples 
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were boiled for 5 min at 95°C in the presence of 4x concentrated Sample Buffer (see Table 
11). 
 
Table 11. Solutions used performing SDS-PAGE analysis.  
4x Sample buffer Coomassie staining solution 
110 mM Tris pH 6.8  7% (w/v) acetic acid  
16% glycerol  50% (w/v) EtOH  
4% (w/v) SDS 0.2% (w/v) Coomassie Brilliant Blue R-250  
5% 2-ME  
0.6% bromphenol blue   
 
Coomassie staining 
The gels were placed in a plastic container and briefly rinsed with water. Next, Coomassie 
staining solution (see Table 11) was added to fully cover the gel and was incubated for at 
least 30 min on an agitating shaker. The gels were destained in water.  
 
Silver staining 
Silver staining protocol was based on the Bloom method ([177] and Table 12).  
 
Table 12. Silver staining solutions. 
Solution Ingredients 
A 10%  acetic acid, 45% methanol 
B 0.8 mM Na2S2CO3 
C 2 mg/mL AgNO3, 0.026% formaldehyde 
D 6% Na2CO3, 0.0185% formaldehyde, 16 µM Na2S2CO3 
 
The gel was rinsed with distilled water and fixed in solution A for 2 min and again for 
20 min using fresh buffer (50 rpm). Subsequentially, the gel was washed two times for 10 
min with 50% ethanol and once for 10 min with 30% ethanol. Next, the gel was sensitized in 
buffer B by 60 s incubation (50 rpm) and washed three times for 20 s in distilled water. The 
staining was performed using solution C for 20 min (50 rpm) followed by the washing step 
(3x, 20 s in distilled water). Reduction was performed using solution D until the band 
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intensity reached satisfying intensity. The reaction was stopped by the addition of 10% acetic 
acid. Finally, the solution was exchanged to 1% acetic acid and incubated for further 20 min. 
The gels were then stored in distilled water. 
 
 
6.4.3 Electrophoretic mobility shift assays (EMSA) 
 
The assays performed on E. cuniculi proteins shown in Figure 28 were by Prof. David Auble 
(Department of Biochemistry and Molecular Genetics, University of Virginia Health System, 
Charlottesville, USA) as described [47], [89] using 47 bp oligonucleotide labeled with 
fluorescein at the 5’ end of one strand (5’–
GGGTACGGCCGGGCGCCCCGGATGGGGGGCTATAAAAGGGGGTGGGC–3’ top). 
The assays shown in Figure 9 were performed as follows. DNA oligos (ds 5’–
CAGTACGGCCGGGCGCCCGGCATGGCGGCCTATAAAAGGGTC–3’, top strand) were 
mixed with TBP at 20 and 200 nM final concentration, respectively, in a final volume of 15 
µL. The DNA–TBP complexes were incubated for 5 min at 4°C. Subsequently, 15 µL of 
serial dilutions of NC2 or NC2β were added (covering the range from 1 to 10 molar excess 
over TBP). The samples were further incubated for 5 min at 4°C. Next, 20 µL of each sample 
were loaded onto 0.5% agarose gel prepared in 1xTAE (40 mM Tris pH 8.0, 20 mM acetic 
acid, 1 mM EDTA) and run at 4°C at 60V for approximately 1h in 1x TAE buffer. All DNA 
and protein dilutions were prepared in 20 mM Tris 7.5, 100 mM NaCl, 5 mM MgCl2 and 
10% (v/v) glycerol. To enable visualization of the DNA-bound complexes, the 5’ end of the 
bottom strand was labeled with 5-FAM. The visualization was performed using Typhoon 
9400 fluorescence scanner (GE Healthcare). 
 
 
6.4.4 Sample preparation for crystallization and analytical purposes 
 
For the preparation of the complex thawed aliquots of single components were mixed in a 
stepwise manner and purified by gel filtration. For the DNA-containing complexes first DNA 
and TBP were mixed in 1.2:1 to 1.5:1 molar ratio and incubated at 4° for 5 minutes. At higher 
concentrations of the stocks protein precipitation was common at this step. After addition of 
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5 M NaCl stock so that the final concentration increased from ~200 to 300 or 400 mM of 
NaCl the precipitate resolubilized. In the second step NC2/NC2β was added so that the molar 
ratio is equal and the sample was incubated for another 5 min followed by the final addition 
of Mot1NTD/Mot1NTD∆latch/Mot1/Mot1∆latch, 5 min incubation and centrifugation. The amount 
of Mot1 was always substoichometric to DNA, TBP and NC2 in order to avoid any presence 
of free Mot1 constructs. Any remaining DNA single proteins or lower-order complexes were 
easy to separate from the main complex fraction in contrast to free Mot1 and homodimeric 
Mot1NTD and Mot1NTD∆latch. In the case of complexes formed without DNA, Mot1 was always 
substoichometrically mixed with NC2/NC2β and TBP (usually 1:1.5). In this case the order 
of adding the components did not affect the complex formation. To separate the complex of 
interest from the excess of single components the sample was applied onto Superdex 200 
10/300GL or Superdex 200 Increase 10/300GL columns. For analytical purposes, Superdex 
200 5/150 GL or Superdex 200 Increase 5/150 columns were used (all from GE Healthcare). 
Gel filtration experiments shown in section 4.1.1 were performed in 20 mM MES (KOH) pH 
6, 60 mM KCl, 5 mM MgCl2 and 2 mM DTT buffer.  
 
 
 
6.5 X-ray crystallography 
 
6.5.1 Crystallization 
 
For the crystallization experiments fractions containing homogeneous complex were 
concentrated to ~2–5 mg/mL and centrifuged before the setups. The complexes were 
screened for crystallization in a 96 well sitting-drop format (MRC Crystallization Plate, 
Molecular Dimensions) using commercial screens using Phoenix Crystallization robot (Art 
Robbins). After obtaining initial hits the crystals were optimized by growing in hanging drop 
vapor diffusion format at 22°C by mixing 1 µL of the sample with 1 µL of the reservoir (500 
µL). Seeding experiments were performed using Seeding Tool from Hampton Research after 
one hour to one day of equilibration. 
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Mot1NTD∆latch/Mot1NTD–TBP–DNA–NC2 complex crystals 
Sample preparation in gel filtration was performed in 20 mM MES, 60 mM KCl, 5 mM 
MgCl2 and 2 mM DTT as described in section 6.4.4. The crystals of the 
Mot1NTD∆latch/Mot1NTD–TBP–DNA–NC2 complex grew for 1–14 days only in conditions 
containing PEG polymers as precipitants with no obvious preferences for salts, additives or 
pH. In all of the refined conditions crystals were characterized by very similar morphology 
and growing behavior. Table 13 and Table 14 list all DNA nucleotides tested. 
Oligonucleotides used for crystallization experiments were HPLC- or PAGE-purified and 
obtained from Biomers in a lyophilized form. These oligomers were resuspended in 40 mM 
TRIS pH 8.0, 100 mM NaCl, 10 mM MgCl2 at 1mM final concentration, mixed with the 
complementary strand in 1:1 molar ratio and annealed. The annealing process was performed 
by heating up the sample to 95ºC, followed by 5 min incubation at this temperature and 
gradual cooling down to reach the final room temperature ( 0.1°C/s). 
Despite extensive crystal optimization, Mot1NTD∆latch–TBP–DNA–NC2 complex 
crystals did not show diffraction better than ~7 Å. Different post-crystallization crystal 
handling methods like crystal annealing, dehydration or crosslinking with glutaraldehyde 
were applied in order to improve the diffraction quality. None of them showed any positive 
effect. Crystals of Mot1NTD–TBP–DNA–NC2 complex showed very similar morphology and 
the preference for crystallization conditions although the length of the DNA was slightly 
different. Best crystals of Mot1NTD–TBP–DNA–NC2 complex were grown containing 0.2 M 
imidazole malate pH 5.0–6.0 and 9–16% PEG4000. Diffraction quality crystals were 
obtained from the streak-seeded selenomethionine-derivatized Mot1NTD–TBP–DNA–NC2 
complex grown in 0.2 M imidazole malate pH 5.1 and 11% PEG4000. Native crystals of the 
complex from the same condition were used for the seeding.  
 
Table 13. DNA oligos used in the crystallization experiments including Mot1NTD∆latch construct.  
The sequence of only one strand in presented 
 
Name Construct Sequence 
12/8/6 26ds GTGAAGTAGGGCTATAAAAGGGGGTG 
12/8/6-2(5)tb 24ds + 5’overhangs GTGAAGTAGGGCTATAAAAGGGGG top 
8/8/8 24ds AGTAGGGCTATAAAAGGGGGAGTA 
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10/8/6 24ds GAAGGGGGGCTATAAAAGGGGGTG 
8/8/8-2(3)t 22ds + 3’ overhang top AGTAGGGCTATAAAAGGGGGAGTA top 
8/8/8-2(3)b 22ds + 3’ overhang  TACTCCCCCTTTTATAGCCCTACT bot 
10/8/6-2(5)t 22ds + 5’ overhang top GAAGTAGGGCTATAAAAGGGGGAG top 
10/8/6-2(3)b 22ds + 3’ overhang bot CTCCCCCTTTTATAGCCCTACTTC bot 
9/8/6 23ds AAGTAGGGCTATAAAAGGGGGTG 
8/8/6 22ds AGTAGGGCTATAAAAGGGGGTG 
8/8/6-2(5)t 20ds + 5’ overhang top AGTAGGGCTATAAAAGGGGGAG 
8/8/6-2(3)t 20ds + 3’ overhang top AGTAGGGCTATAAAAGGGGGAG top 
8/8/6-2(3)b 20ds + 3’ overhang bot CTCCCCCTTTTATAGCCCTACT bot 
8/8/6-2(3)b 20ds + 3’ overhang bot CTCCCCCTTTTATAGCCCTACT bot 
7/8/6 21ds ATAGGGCTATAAAAGGGGGTG 
8/8/4 20ds AGTAGGGCTATAAAAGGGGG 
5/8/6 19ds GGGGCTATAAAAGGGGGTG 
8/8/3 19ds AGTAGGGCTATAAAAGGGG 
8/8/1 17ds AGTAGGGCTATAAAAGG 
3/8/3 14ds GGCTATAAAAGGGG 
 
Table 14. DNA oligos used in the crystallization experiments including Mot1NTD construct.  
The sequence of only one strand in presented 
 
Name Construct Sequence 
10/8/6 24ds GAAGGGGGGCTATAAAAGGGGGTG 
10/8/8 26ds GAAGTAGGGCTATAAAAGGGGGAGTA 
9/8/9 26ds AAGTAGGGCTATAAAAGGGGGTGGCA 
8/8/9 25ds AGTAGGGCTATAAAAGGGGGTGGAA 
9/8/8 25ds AAGTAGGGCTATAAAAGGGGGGTGGC 
8/8/9 25ds AGTAGGGCTATAAAAGGGGGTGGCA 
8/8/8 24ds AGTAGGGCTATAAAAGGGGGTGGC 
8/8/8-2(3)t 22ds + 3’ overhang top AGTAGGGCTATAAAAGGGGGAGTA top 
8/8/8-2(3)b 22ds + 3’ overhang bot TACTCCCCCTTTTATAGCCCTACT bottom 
8/8/7 23ds AGTAGGGCTATAAAAGGGGGTGG 
7/8/8 23ds GTAGGGCTATAAAAGGGGGAGTA 
8/8/4 20ds AGTAGGGCTATAAAAGGGGG 
8/8/1 17ds AGTAGGGCTATAAAAGG 
3/8/3 14ds GGCTATAAAAGGGG 
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Mot1NTD–TBP–NC2β complex crystals 
Sample preparation in gel filtration was performed in 20 mM HEPES (HCl), 100 mM NaCl, 
1 mM MgCl2 and 2 mM DTT as described in section 6.4.4. The initial crystals appeared in 
few PEG-containing conditions and were growing in form of needle bundles or clusters of 
thin plates, which were useless for diffraction experiments or diffracted very poorly 
(maximally 5 Å). Improved crystal morphology and diffraction quality was obtained by 
streak seeding of the self-nucleated crystals grown in conditions containing 0.1 M sodium 
citrate pH 5–6 and PEG4000, supplemented with 0.1 M sodium malonate, 0.2 M ammonium 
sulphate, or 0.1 M magnesium acetate. Best diffraction quality crystals (3.3 Å) were obtained 
from the condition containing sodium malonate and appeared 3–14 days after seeding. The 
seeded crystals were not extensively optimized (tested on the synchrotron only once) and it is 
thus likely that further refinement would lead to even better diffracting crystals. Crystals 
grown in magnesium acetate conditions were quite reluctant to seeding and turned out to be 
Mot1NTD–TBP crystals of the same space group, unit cell dimensions and organization of the 
asymmetric unit as in already published structure [47].  
 
 
6.5.2 Data collection and processing 
 
Before the data collection crystals were flash-frozen in liquid nitrogen using 25% glycerol or 
25% ethylene glycol (final v/v) as a croprotectant. 
 
Mot1NTD–TBP–DNA–NC2 structure 
Diffraction data was collected at the European Synchrotron Radiation Facility (ID-29) at 
100K and λ=0.9796 Å. The reflections were indexed, integrated and scaled with XDS [178] 
in the space group C 1 2 1 (a= 150.6 Å, b= 140.3 Å, c= 90.8 Å, α= 90.0°, β= 113.7°, γ= 
90.0°). The calculation of Matthew’s coefficient (MATTHEWS_COEF, CCP4 package [131], 
[179], [180]) suggested one complex per asymmetric unit and 60% of the solvent content. 
The calculation is based on the analysis of the solvent content distribution among PDB 
entries giving the most probable number of molecules in the asymmetric unit of a known 
molecular mass.  
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Unfortunately, the verification of the presence and location of the selenium K 
absorption edge was not performed due to technical problems at the beamline and the data set 
was collected at the theoretical wavelength of the selenium K absorption edge. Owing to 
poor crystal diffraction and lack of experimentally determined optimal wavelength, the 
anomalous signal was insufficient to allow experimental phasing. Nevertheless the structure 
was successfully solved by molecular replacement method with Phaser, part of the CCP4 
software suite [131], [181] using first E. cuniculi Mot1NTD and TBP (PDB-ID 3OC3 [47]) as 
search models. The initial model of DNA was based on the human TBP–DNA–NC2 structure 
(PDB-ID 1JFI [107]) Homology model of the NC2 heterodimer was prepared using 
CHAINSAW (CCP4 [131], [182]) based on the human TBP–NC2–DNA complex structure 
and the C subunit of NF-Y complex (PDB-ID 4AWL [109]). The NC2 subunits were 
manually fitted into the density. The structure was refined in BUSTER (v. 2.10.1) at 3.8 Å 
using TLS refinement strategy [183] and manually rebuilt in Coot [184]. Applying density 
modification methods, i.e. solvent flattening with PARROT (CCP4) [131], [132] as well as B-
factor sharpening and calculation of feature-enhanced 2Fo – Fc map with PHENIX [133] 
enabled unambiguous density interpretation. The histone fold region was characterized by 
relatively high B-factors and poor density and therefore the side chains of the residues NC2α 
15–89 and NC2β 12–101 were omitted in the final model. The sequence register was 
confirmed by computing anomalous difference density map, which showed signal of the 
selenium atoms (Figure 12).  
 
Mot1NTD–TBP–NC2β structure 
Diffraction data was collected at the X06SA beamline of the Swiss Light Source (Villigen, 
Switzerland). A 180 ° dataset was collected at λ= 0.9797 Å and 100 K. The data set was 
indexed, integrated and scaled in space group P 1 21 1 (a=116.8 Å, b=150.1 Å, c=172.8 Å, 
α=90.0°, β=107.1°, γ=90.0°) to 3.3 Å using XDS [178]. The calculation of Matthew’s 
coefficient [131], [179], [180] suggested four complexes per asymmetric unit with 55% 
solvent content. The structure was solved by molecular replacement with Phaser, part of the 
CCP4 software suite [131], [181] using the E. cuniculi Mot1NTD and TBP from the Mot1NTD–
TBP complex crystal structure [47] as separate search models. The NC2β subunit was 
modeled into the 2 Fo – Fc and Fo – Fc density maps using Coot [184] and iteratively rebuilt 
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and refined with PHENIX [133] at 3.3 Å using non-crystallographic symmetry restraints 
(NCS) and group B-factor refinement strategy. The sequence register of four short α-helices 
most probably belonging to NC2β chains could not be unambiguously defined due to the 
discontinuities in the polypeptide chains and relatively low resolution. Thus, these helices 
were included in the models as poly-alanine stretches. Higher resolution data would be 
required to confirm the identity of these helices and assure the sequence register. 
 
 
 
6.6 Electron microscopy 
 
6.6.1 Sample preparation 
 
The complex formation protocol was same as described in section 6.4.4 with some 
modifications; the complex was formed on a 38 bp DNA substrate (5’–
CAGGCCGGGCGCCCGGCATGGCGGCCTATAAAAGGGTC–3’, top strand and 
20 mM HEPES pH 8.2, 60 mM KCl, 5 mM MgCl2 and 2 mM DTT was used in the gel 
filtration step. After the separation, the main peak fractions were supplied with 1 mM ABF 
(formed by mixing ADP:BeCl2:NaF in 1:1:4 molar ratio), 1 mM AGS or 1 mM ADP added 
right after the gel filtration. The ADP stock at 60 mM was prepared in 0.5 M HEPES pH 8.0 
and AGS at 50 mM in 0.1 M HEPES 8.0. According to the Bradford assay, the final 
concentration of the sample used for the experiment was 25 µg/mL. Negatively stained grids 
were prepared immediately after the complex sample was available.  
Further handling of the sample, data collection, processing and validation was done 
by Jan Schuller (Förster Group, Max Planck Institute of Biochemistry, Martinsried, 
Germany) and is described in detail elsewhere [89]. 
 
 
6.6.2 Modeling into EM density 
 
The rigid-body docking of Mot1NTD–TBP–DNA–NC2 crystal structure was performed using 
colores applying a 10° sampling step size to the down-filtered (22 Å) search probe [144]. The 
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DNA was omitted from the model. Additionally, Laplacian filter maximizing the fitting 
contrast was applied. The fitting was preformed for the correct and mirrored reconstruction 
and resulted in several possible fits for the Mot1NTD–TBP–NC2 module. After manual 
inspection, one of the solutions (for the rightful hand) was qualified as the correct solution. 
The other fits were nonsense fits resulted from template drifting, which often occurs at low 
resolution when the structure represents only a part of the density it is docked into [144].  
 
 
6.7 Chemical protein–protein crosslinking and mass spectrometry 
analysis 
 
6.7.1 Sample preparation 
 
The complex formation protocol used is described in section 6.5.1. The complex was first 
formed in the presence of 42 bp promoter DNA  in 20 mM HEPES pH 8.2, 60 mM KCl, 5 
mM MgCl2 (ds 5’–CAGTACGGCCGGGCGCCCGGCATGGCGGCCTATAAAAGGGTC–3’ 
top strand). After the separation, the main peak fraction samples were supplied with the 
nucleotides as described in section 6.4.4. The final concentration of the sample used for the 
experiment was 0.66 mg/mL, as calculated by the Bradford assay.  
 
 
6.7.2 Titration of the crosslinker 
 
Di-sulfo-succinimidyl-glutarate (DSSG, Creative Molecules) was initially dissolved in 
dimethylformamide (DMF) to a final concentration of 25 mM (heavy/light). The stock was 
diluted with water and added to the protein sample (~50 µg) placed in a 1.5 mL 
polypropylene tube to yield final desirable molar concentration (0.05–2 lysines:DSSG). The 
crosslinking reaction was carried out at 30°C with continuous shaking and quenched after 35 
min by the addition of 0.1 (v/v) 1 M TRIS pH 8.5 followed by 15 min incubation at 30°C. 
Titration of DSSG was analyzed by running 1 µg of each the crosslinked sample on an SDS-
PAGE gel followed by silver staining. The titration of the crosslinker was done in order to 
find optimal concentrations of the compound under given conditions leading to maximal 
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crosslinking efficiency which does not cause formation of aggregates between the complexes 
in the solution. Molar ratio of 1:1 lysines:DSSG was selected for the main experiments. 
Trypsine digestion, extraction of the peptides, and mass spectrometric analysis of the 
crosslinked peptides was performed by Gabriele Stoehr (Hopfner Group, Gene Center, LMU, 
Munich). Experimental procedures explaining this part of the experiments can be found 
elsewhere [89]. 
 
 
6.7.3 Analysis of the theoretical crosslinks within the Mot1NTD–TBP–NC2 module 
 
In order to analyze the distribution of distances between all lysines within the complex, script 
K_sites_xlinks.sh was created (K_sites.xlinks.sh, Script 1). The script reads input files 
provided as continuous one-letter amino acid sequences of unlimited number of protein 
sequences (but one file per each protein) and creates an output list (in CSV format) 
containing all possible pairs of lysines within this complex. Additionally, the number of 
lysines found in each sequence, total number of lysines nad the number of “nonredundant” 
crosslinks are written to a .txt file. The final output CSV file additionally includes redundant 
“crosslinks” with reversed order of sites, e.g. K125 ProteinA–K33 ProteinB as well as K33 
ProteinB–K125 ProteinA and, similarly, lists “crosslinks” to the same residue, i.e. K125 
ProteinA–K125 ProteinA. These are, however, ignored by Chimera Xlink analyzer plug-in 
which reads the CSV output file, maps the crosslinks on the structural models and writes out 
the distances [185].  
 
 
6.7.4 Analysis of the crosslinks between the Mot1NTD–TBP–NC2 module and Mot1CTD 
 
The set of Mot1CTD orientations (n=20,000) was generated using RANCH, part of the EOM 
package [141]. The eight amino acid linker between Mot1NTD and Mot1CTD (not present in 
any of the atomic models) was assumed to flexibly join these two domains. Models were 
generated in the “compact” mode, i.e. using Cα angles distribution consistent with disordered 
proteins but forcing the reconstructed linkers to be rather compact [141]. Next, all models 
were displayed and the distances were measured using a set of scripts enabling easy handling  
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Script 1. K_sites.xlinks.sh 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
#!/bin/bash 
# K_sites_xlinks.sh 
# Generate a file with a list of all lysines present in the *.seq input files 
for f in *.seq;do cat $f | sed 's/\(.\{1\}\)/\1 /g' > $f.seq2;done 
for f in *.seq.seq2;do cat $f | tr ' ' '\n' | cat -n | sed 's/ //g' | sed 's/\t/ /g'> $f.seq3;done 
for f in *.seq.seq2.seq3;do sed '/K/!d' $f > $f.seq4;done 
for f in *.seq.seq2.seq3.seq4;do awk '{print $0,FILENAME}' $f > $f.seq5;done 
for f in *.seq.seq2.seq3.seq4.seq5;do awk -F. '{print $1}' $f > $f.seq6;done 
for f in *.seq.seq2.seq3.seq4.seq5.seq6;do cat $f >> list.txt;done 
 
# Generate a file with a list of all possible linkages between lysines 
while IFS= read -r i 
 do while IFS= read -r k 
  do printf "%s %s\n" "$i" "$k" 
  done < list.txt  
 done < list.txt > total_xlinks.txt 
 
awk '{print $0,"40"}' total_xlinks.txt > total_xlinks_40.txt #Adds column with ld-Score value (40) 
cut -d" "  -f-1,3-4,6- total_xlinks_40.txt > total_xlinks_40_cut.txt # Deletes columns with residue name 
awk '{if($2==$4) print $0,"intra-protein xl";else print $0,"inter-protein xl"}'total_xlinks_40_cut.txt / 
> total_xlinks_40_cut_anal.txt # Adds inter/intra link tag to each crosslink 
sed -i 1i"AbsPos1 Protein1 AbsPos2 Protein2 ld-Score XLType" / total_xlinks_40_cut_anal.txt # Adds headers 
 
# Write as .CSV file and define inter- and intraprotein crosslinks 
sed 's/ /,/g' total_xlinks_40_cut_anal.txt > K_sites_xlinks1.csv 
sed 's/intra-protein,xl/intra-protein xl/g' K_sites_xlinks1.csv > K_sites_xlinks2.csv 
sed 's/inter-protein,xl/inter-protein xl/g' K_sites_xlinks2.csv > K_sites_xlinks.csv 
 
# Write out additional file with number of found sites and generated crosslinks 
for f in *.seq.seq2.seq3.seq4;do wc -l $f >> 1.txt;done 
awk '{s+=$0} END {print s " total_lysines_found"}' 1.txt >> 1.txt 
echo $(wc -l < total_xlinks.txt) "total_created_xlinks" >> 1.txt 
awk -F. '{print $1}' < 1.txt > 2.txt 
tac 2.txt > sites.txt 
a=$(awk 'FNR==1 {print $1}' sites.txt) 
b=$(awk 'FNR==2 {print $1}' sites.txt) 
c=$(((a - b) / 2)) 
echo "$c total_non-redundant_xlinks" >> sites.txt 
 
# Removes all files except for the script, input and output files 
shopt -s extglob 
rm !(*.seq|K_sites_xlinks.csv|sites.txt|K_sites_xlinks.sh) 
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of the generated data. First of them (pymol_template.py, Script 2) was a modified version of  
PyMOL script “Measure Distance” (source code available at http://www.pymolwiki.org/). 
Running it would open a file defined as name, create file name.txt and write out distances 
between Cα atom of residue 1 belonging to chain A and residue 2 belonging to chain B. 
Separate template scripts were created for each of the crosslinking data sets, where all 
nonredundant linkages detected in particular experiment were listed. Since the total number 
of the models would not allow to manually run this script for each of the computer models, 
another script was used to save a separate *.py file for each of the models by changing the 
name field in pymol_template.py (distances_batch.sh, Script 3). Third script created a text 
file (batch.txt), which would be then finally launched in PyMOL. As a result, *.pdb.py.txt 
files were created, each containing number of the distances between the atoms defined in the 
template pymol_template.py file. 
 
Script 2. Modified “Measure Distance” script executed in PyMOL (pymol_template.py). 
 
 
 
 
 
 
Script 3. distances_batch.sh. 
 
 
 
 
 
 
 
 
 
from pymol import cmd 
cmd.load('/path/name') 
f=open('/path/name.txt','w') 
dst=cmd.distance('i. 1 and chain A and n. CA','i. 2 and chain B and n. CA') 
f.write("%8.3f\n"%dst) 
f.close() 
cmd.reinitialize() 
#!/bin/bash 
# distances_batch.sh 
 
# Substitutes the name field in the template script for the name of the model 
for f in *.pdb;do sed -e "s/name/$f/" path/pymol_template.py > path/$f.py;done 
 
# Generates a batch file to run the modified template scripts for each of the models 
for f in *.pdb.py;do echo "run path/$f" >> batch.txt;done 
 
# Removes all files except for the script, input and output files 
shopt -s extglob 
rm !(*.pdb|distances_batch.txt|distances_batch.sh) 
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Finally, the models were scored according to the number of crosslinks violating the 30 Å 
cutoff distance [142]. To perform this, script scores.sh (Script 4) was used to count the 
number of distances, which are greater or equal to a given value (here: 30) and write the 
number of counts to *.pdb.py.txt.violations files. Finally, same script enabled to count the 
number of the crosslinks which were not fulfilled according to the used threshold value 
defined in violations.sh and write out the final score to a *.pdb.py.txt.violations.score file for 
each of the models. To enable easy data handling, all scores were combined into a single text 
file score_list.txt, where name of the model and the final score was listed. 
 
Script 4. scores.sh. 
 
 
 
 
 
 
 
 
 
 
For the residues NC2α K61, K62, K92 and NC2β K27, which were not visible in the crystal 
structure (i. e. comprising short loop regions) but important for the analysis, the distances 
refer to the position which could be unambiguously modeled based on the crystal structure of 
NF-Y complex (PDB-ID 4AWL [109]).  
 
 
6.8 Figure preparation 
 
Molecular graphics and analyses were performed with the UCSF Chimera package [146], 
PyMOL Molecular Graphics System (v. 1.5.0.4 Schrödinger, LLC), OriginPro 8G 
(OriginLab) and Adobre Illustrator CS4 v14.0.0 (Adobe Systems). 
#!/bin/bash 
# scores.sh 
 
for f in *.txt;do awk '$1>=30' $f > path/$f. violations;done # Lists only crosslinks >= 30 Å 
 
for f in *.violations;do wc -l $f > path/$f.score;done # Counts the violated crosslinks 
 
for f in *.score;do cat *.score > score_list.txt;done # Lists violation score for each model 
 
# Removes all files except for the script, input and output files 
shopt -s extglob 
rm !(*.txt|score_list.txt|scores.sh) 
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8. ABBREVIATIONS 
 
 
ABF ADP-beryllium fluride 
ADP adenosine diphosphate 
AGS adenosine 5'-O-(3-thio)triphosphate, ATPγS 
ATP adenosine triphosphate 
β-ME β-mercaptoethanol 
bp base pairs 
ChIP chromatin immunoprecipitation 
CRIP crosslinking restriction digest-coupled immunoprecipitation  
CSB Cockayne syndrome protein B 
CX-MS protein–protein crosslinking coupled to mass spectrometry  
dsDNA double-stranded DNA 
DSSG di-sulfo-succinimidyl-glutarate  
DTT dithiothreitol 
EM electron microscopy 
EMSA electrophoretic mobility shift assay 
FEM feature-enhanced map 
FRAP fluorescence recovery after photobleaching  
FRET Förster resonance energy transfer 
GTF general transcription factor 
HEAT Huntingtin, elongation factor 3, protein phosphatase 2A, lipid kinase TOR 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
IDB inhibitory DNA binding surface 
Mot1 Modifier of transcription 1 
NC2 Negative Cofactor 2 
NES nuclear export signal 
NLS nuclear localization sequence 
NTP nucleoside triphosphate  
ORGANIC sequencing of occupied regions of genomes from affinity-purified naturally isolated chromatin 
PEG polyethylene glycol 
PIC preinitiation compelx 
RCE restriction digest-coupled electrophoretic mobility shift 
r.m.s.d. root mean square deviation 
RNA pol RNA polymerase 
SDS-PAGE sodium dodecyl sulfate polyacrylamide gel electrophoresis  
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ssDNA single-stranded DNA 
Swi2/Snf2 Switching defective/Sucrose nonfermenting 2 
TRIS tris-hydroxymethyl-aminomethane 
WCE whole cell extract 
WT wild type 
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